TW201902524A - Injection device capable of preventing the injection needle from falling off from the injection barrel and enabling the syringe to be attached and detached from the injection device - Google Patents

Injection device capable of preventing the injection needle from falling off from the injection barrel and enabling the syringe to be attached and detached from the injection device Download PDF

Info

Publication number
TW201902524A
TW201902524A TW106117879A TW106117879A TW201902524A TW 201902524 A TW201902524 A TW 201902524A TW 106117879 A TW106117879 A TW 106117879A TW 106117879 A TW106117879 A TW 106117879A TW 201902524 A TW201902524 A TW 201902524A
Authority
TW
Taiwan
Prior art keywords
needle
injection
movable bracket
injection device
syringe
Prior art date
Application number
TW106117879A
Other languages
Chinese (zh)
Other versions
TWI731091B (en
Inventor
中沢陽介
佐藤征嗣
佐藤敬
假谷道宏
田中聡
Original Assignee
資生堂股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 資生堂股份有限公司 filed Critical 資生堂股份有限公司
Priority to TW106117879A priority Critical patent/TWI731091B/en
Publication of TW201902524A publication Critical patent/TW201902524A/en
Application granted granted Critical
Publication of TWI731091B publication Critical patent/TWI731091B/en

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

This invention relates to an injection device 1 which injects the content into a subject by using a syringe having a plunger, an injection barrel into which the plunger is inserted, and an injection needle which is composed of a needle base connected to the injection barrel and a needle tube punctured into the subject. The injection device 1 comprises a contact head 10, which is capable of being in contact with the subject, and formed into an opening portion through which the needle tube passes; a movable bracket 30, which holds the injection barrel and the injection needle; a support mechanism 20, which is fixed on the contact head; and a content injection control mechanism 50, which presses the plunger into the interior of the injection barrel. The injection barrel and the injection needle are moved relative to the contact head by moving the movable bracket along the support mechanism. The syringe is detachable with respect to the injection device.

Description

注射裝置Injection device

本發明涉及注射裝置,更具體地,涉及適於向組織內注射、供給、或投與包括細胞在內的各種物質的裝置。The present invention relates to an injection device and, more particularly, to a device adapted to inject, supply, or administer various substances including cells into a tissue.

在細胞治療等中,希望在皮膚內的治療部位精密地按照預期的量將細胞等預定物質於預定的深度注射至受實驗者。 另外,在將微量的細胞等物質注入單一層或單一區域內時,還需要將預定的量分割為多次,並從多個不同方向分散進行注入。 此外,在上述的將預定量的內容物分割為多次並從多個不同方向分散進行注入的情況下,希望使對被檢體的影響為均等分割,故,希望在被分割的多次中的每次都按照預定的相同速度進行注入。 為了解決這樣的問題,提出了專利文獻1,其中,設計了一種在注射裝置內對注射針進行固定的注射針外套(housing),注射針被固定在其內部,注射筒被著脫(裝卸)自由地安裝在被固定了的注射針上。在該注射裝置內,藉由內部的驅動系統和後退系統,可按照預定的速度執行注入動作。 [先前技術文獻] [專利文獻] [專利文獻1]特表2015-505487號公報In cell therapy or the like, it is desirable to inject a predetermined substance such as a cell into a subject at a predetermined depth in a desired amount in a treatment site in the skin. Further, when a substance such as a small amount of cells is injected into a single layer or a single region, it is necessary to divide the predetermined amount into a plurality of times and to perform dispersion injection from a plurality of different directions. Further, in the case where the predetermined amount of the content is divided into a plurality of times and dispersed and injected from a plurality of different directions, it is desirable to divide the influence on the subject into equal divisions. Therefore, it is desirable to divide the plurality of times. Each time, the injection is performed at the same predetermined speed. In order to solve such a problem, Patent Document 1 has been proposed in which an injection needle casing that fixes an injection needle in an injection device is designed, the injection needle is fixed inside, and the syringe is detached (loading and unloading). It is freely mounted on the fixed injection needle. In the injection device, the injection operation can be performed at a predetermined speed by the internal drive system and the retraction system. [Prior Art Document] [Patent Document] [Patent Document 1] Japanese Patent Publication No. 2015-505487

[發明要解決的課題] 然而,在專利文獻1的技術中,由於注射針被固定在內部,在對多個患者或受實驗者使用該裝置實施注射的情況下,傳染病、感染症等的感染、及注射針的摩耗等所引起的穿刺痛的風險較高,故,需要使注射裝置本身為一次性用品。 另外,在作為對象的注射裝置和注射器用的注射針為無法著脫的一體化的結構中,就裝置而言,會作為更高度的醫療機器而被管理,裝置的申報或搬送的管理也都很會嚴格。 此外,作為藉由注射而進行注入的內容物,如果使用黏性高的膠(gel)狀結構的物質,則使用時壓力較高,存在注射筒會從被固定了的注射針上脫離的可能性。 因此,本發明鑑於上述緣由,以提供一種使用時可防止注射針從注射筒脫落並可使注射器著脫的注射裝置為目的。 [用於解決課題的手段] 根據本發明的一方式,一種注射裝置,藉由具有活塞、插嵌該活塞的注射筒、及由與該注射筒連接的針基和向被檢體內穿刺的針管所構成的注射針之注射器,使內容物注入該被檢體,該注射裝置的特徵在於,具有:接觸頭,可與該被檢體接觸,並形成了供該針管穿過的開口部;可動支架,對該注射筒和該注射針進行保持;支撐機構,固定在該接觸頭上;及內容物注入控制機構,將該活塞壓入該注射筒的內部。藉由該可動支架沿該支撐機構進行移動,使該注射筒和該注射針相對該接觸頭進行移動。該注射器可相對該注射裝置進行著脫。 [發明的效果] 根據本發明的一方式,注射裝置在使用時可防止注射針從注射筒脫落並可使注射器著脫。[Problems to be Solved by the Invention] However, in the technique of Patent Document 1, since the injection needle is fixed inside, when a plurality of patients or subjects are used to perform injection using the device, infectious diseases, infectious diseases, and the like The risk of puncture pain caused by infection, abrasion of the injection needle, and the like is high, and therefore it is necessary to make the injection device itself a disposable article. In addition, in the case where the injection device for the target and the injection needle for the syringe are in an integrated structure that cannot be removed, the device is managed as a higher medical device, and the device is also declared or transported. Very strict. Further, as a content to be injected by injection, if a substance having a high viscosity of a gel-like structure is used, the pressure is high during use, and there is a possibility that the syringe will be detached from the fixed injection needle. Sex. Accordingly, the present invention has been made in view of the above circumstances, and an object of the present invention is to provide an injection device which can prevent the injection needle from coming off the syringe and allowing the syringe to come off. [Means for Solving the Problem] According to one aspect of the present invention, an injection device has a syringe having a piston, a syringe inserted therein, and a needle base connected to the syringe and a needle penetrating the inside of the subject The syringe of the injection needle is configured to inject the contents into the subject, and the injection device is characterized in that: the contact head is in contact with the subject, and an opening portion through which the needle tube passes is formed; a holder for holding the syringe and the injection needle; a support mechanism fixed to the contact head; and a content injection control mechanism for pressing the piston into the interior of the syringe. The movable bracket is moved along the support mechanism to move the syringe and the injection needle relative to the contact head. The syringe is detachable relative to the injection device. [Effects of the Invention] According to one aspect of the present invention, the injection device can prevent the injection needle from coming off the syringe and can cause the syringe to come off during use.

圖1是本申請的第1實施方式的注射裝置的說明圖。(a)是示意圖,(b)是側視圖。 [整體說明] 注射裝置1是用於安裝將包括細胞懸濁液等物質的內容物注入被檢體(人、動物、個別臟器、皮膚等)的注射器之注射裝置。注射裝置1發揮用於使用注射器將適量的內容物注入被檢體的注入用注射筒器(syringe)支架(holder)(注射器支架)的功能。 注射裝置具有接觸頭10、支撐機構20、可動支架30、及內容物注入控制機構50。 接觸頭10可與被檢體接觸,並形成了開口部。接觸頭10位於注射裝置1的前端。後述的針管83相對被檢體進行穿刺動作・拔針動作時,穿過該開口部11(參照圖4(b))。 支撐機構20以預定的角度固定在接觸頭10上。藉由支撐機構20和接觸頭10的結合角度,可設定相對被檢體的注射角度。接觸頭10和支撐機構20可被一體製造,也可分別進行製造後再藉由溶接等固接。 支撐機構20是藉由規定可動支架30的移動的停止位置以擋住可動支架30的支架承受部。 可動支架30保持注射筒84和注射針81(參照圖2(a)),可相對接觸頭10沿支撐機構20進行移動。藉由可動支架30相對接觸頭10進行移動,可使由可動支架30保持的注射筒84和注射針81相對與接觸頭10接觸的被檢體進行移動。藉由該相對移動,注射器80的針管83可相對被檢體向作為穿刺方向的前進方向和作為拔針方向的後退方向進行移動。 內容物注入控制機構50對活塞88相對注射筒84進行壓入。內容物注入控制機構包括按壓部40、引導棒51、連動棒52、連接棒53、及彈性部件54、55(參照圖5)。 這裡,在本發明的注射裝置1中,注射筒和注射針作為注射器,並可進行著脫。圖2是注射器的說明圖,(a)表示組裝後的注射器,(b)表示注射器的分解圖。 如圖2所示,注射器80由注射針81、注射筒84、及活塞88構成。注射筒(cylinder)84收藏內容物,其中插嵌活塞88。具體而言,注射筒84具有收藏內容物的外筒部85、設置在外筒部85的後端的凸緣(flange)86、及筒前端87。 這裡,在本發明的注射裝置內,較佳使用具有1mL的容積的注射器。這樣的1mL的注射器可進行10次100μL的注射或6次166μL的注射。也可使用具有2、5或10mL的注射器。基於注射裝置的具體使用形態,注射器還可具由更大或更小的容積。 注射針81與注射筒84連接。具體而言,注射針81具有外嵌於注射筒84的筒前端87的針基82和向被檢體內進行穿刺的針管83。安置注射器80時,使注射筒84的筒前端87插入注射針81的針基82之中並進行卡合。也可使用具有藉由進行鎖定以使注射針81的針基82和注射筒84的筒前端87不易脫離的結構之注射器。 這裡,適用於本發明的注射裝置的注射針的針管的直徑較佳為位於18~34G、20~30G的範圍。另外,優選為26G、27G或30G。 活塞88(plunger)藉由頭部(後部)88h被按壓而在注射筒84的外筒部85內進行移動,可使內容物從注射器被放出。在活塞88的前端部,接著了作為用於防止液體洩露或異物混入的薄板狀橡膠製填料(packing)(密封元件)之襯墊(gasket)89。 這裡,在本發明中,如圖2(a)所示的注射筒84和注射針81一體化並可一起進行著脫,故,注射筒84內所收藏的內容物不會附著在注射裝置1的內側或者附著極少,藉此注射裝置1可被再利用。這裡,注射筒84和注射針81至少在向注射裝置1進行著脫時和被安裝在注射裝置1內時藉由連接而一體化即可,位於注射裝置1之外時,注射筒84和注射針81可為彼此分開的狀態。 [可動支架(注射器支架)] 圖3表示可動支架30的上表面的放大斷面圖。(a)是斜視圖,(b)是沿(a)的A-A’進行了截斷的斷面俯視圖。 可動支架30具有位於上部的由前方支架310和後方支架320構成的注射器支架及形成了供棒狀部件51、52、53穿過的2個貫穿孔(331、332,參照圖5)的移動支撐部330。另外,作為第1彈性部件的線圈彈簧54、55設置在移動支撐部330的內部。 位於可動支架的上部的310、320具有凸緣嵌合部31、外筒部夾持部32、針基停止部(stopper)33、及圓周面保持部34。 凸緣嵌合部31與注射筒84的凸緣86嵌合。凸緣嵌合部31如圖3(b)所示在俯視圖中為翼(翅膀)形狀的外框形狀,藉由將凸緣86嵌入該外框形狀而使其卡合。藉由該卡合,對凸緣86進行定位,藉此限制凸緣86相對可動支架30向分離方向(後退方向,圖1(b)的箭頭B的方向)進行移動。 外筒部夾持部32從兩側對注射筒84的外筒部85的位置進行夾持並保持。外筒部夾持部32是以沿著筒狀外筒部85的側面的兩側的方式而立起為肋條(rib)狀的線狀突起形狀。藉由該結構,外筒部夾持部32對可動支架30中的外筒部85的側面方向的位移、即、向側面的偏移進行限制。可動支架30即使發生了移動,也可穩定地對保持狀態進行維持。 針基停止部33對注射針81的針基82的移動進行限制。在圖2所示的注射器的例子中,針基82的前端為預定的平面形狀,圖3所示的針基停止部33藉由內徑進行縮徑(設置了段差),可與針基82的前端面接觸。 在圖3(a)中,針基停止部33沿相對注射器80的移動方向而使其停止的方向垂直延伸,儘管針管83可穿過,然而卻是一種針基82的前端(與移動方向垂直的面)與針基停止部33接觸,藉此對注射器80的相對可動支架30的移動進行限制的構成。需要說明的是,針基停止部33也可不與相對注射器80的移動方向而使其停止的方向垂直,例如,藉由使圓周的形狀遞減,也可使針基82停止。或者,在針基82的前端不存在垂直面,並且針基82的形狀朝與注射筒8連接的部分其(針基82)直徑逐漸變粗的情況下,針基停止部33也可藉由與針基82的側面接觸,對注射器80的相對可動支架30的移動進行限制。 藉由該構成,在將注射器80安裝至注射裝置1時和注入動作期間,針基82對可動支架30中的向接近開口部11側的方向(前進方向,圖1(b)的箭頭A的方向)的移動進行限制。 圓周面保持部(針基圓周面保持部)34將注射針81的針基82的圓周面保持為圓周面狀。需要說明的是,圓周面保持部34還可將注射筒84的外筒部85的前端保持為圓周面狀。圖3所示的圓周面保持部34為沿針基82和外筒部85的前端的圓周面方向覆蓋整個圓周面的筒狀形狀。需要說明的是,圓周面保持部34也可不覆蓋全周,例如還可為使針基82和外筒部85的前端的形狀為半圓狀那樣的形狀。藉由該圓周面保持部34,相對可動支架30的針基82和外筒部的側面方向的位移可被限制。藉由該構成,可動支架30移動時,可防止沿保持狀態的側面方向(短邊方向)進行移動(偏移)。 如上所述,在可動支架30中,凸緣嵌合部31限制向注射筒84的分離方向(圖1(b)的箭頭B的後退方向)的移動,針基停止部33限制向注射針81的接近方向(圖1(b)的箭頭A的前進方向)的移動,據此,在移動方向上,注射筒84和注射針81的結合狀態可被維持。 故,即使注射筒84和注射針81與可動支架30一起移動了,也可防止注射針81從注射筒84脫落進而導致內容物洩露至注射裝置1內。 需要說明的是,可動支架30的外筒部夾持部32也可不在沿著注射器80的外筒部85的整個部分處都立起。如圖3(a)所示,藉由設置外筒部夾持部32的突起的一部分中斷了的平面部35,注射器80可較容易地嵌入可動支架30,藉此可提高注射器80著脫時的操作性。 [支撐機構] 基於圖4和圖1(b)對支撐機構20進行說明。圖4(a)是接觸頭10和支撐機構20的斜視圖,(b)是從其他方向觀察的斜視圖。(c)是從接觸頭10和支撐機構20的注入方向觀察的沿著箭頭的圖(arrow view)。接觸頭10和支撐機構20發揮作為相對可移動的可動支架30不動的固定部件(主體)的功能。 支撐機構20相對接觸頭10被進行了固定。藉由接觸頭10和支撐機構20的連接角度,可設定注射器80的針管83的相對被檢體的接觸角度。 用於規定注射角度的支撐機構20和接觸頭10之間的角度較佳為10度~90度的任一者,優選為位於15度~25度的範圍內。 支撐機構20具有上表面蓋部24和側壁23,在支撐機構20的內部,形成了用於引導可動支架30的移動的筒狀的支架引導通道(插入貫穿孔)21。這裡,在位於支撐機構20的後端的側壁23上,形成了供可動支架30插入的作為支架引導通道21的插入孔的入口的開口部23O。 就可使可動支架30沿支撐機構20進行移動的支架引導通道21中的位於下方的部分而言,其發揮作為引導可動支架30進行移動的移動引導軌22的功能。 在支撐機構20的下方,設置了沿側面方向(注入方向)延伸的切口(開口部)25。藉由使下部開放,可防止注射器80進行著脫動作時針管83的前端與注射裝置1內部接觸。 在本實施方式中,就作為移動引導軌22的用於使可動支架30的前端(至少保持注射針81的部分)插入的筒狀插入貫穿孔的支架引導通道21的內圓周面下表面以外的部分而言,其為沿著可動支架30的前端(圓周面保持部34)的形狀之形狀。 如圖4(a)和圖4(c)所示,在支撐機構20中,支架引導通道21的上方和兩個側方被覆蓋成半圓形狀(半圓柱體形狀)。具體而言,支撐機構20具有上表面蓋部24,其沿圓周面方向在上方和側方至少覆蓋注射針81和可動支架30的保持注射針81的部分(針基停止部33和圓周面保持部34)。故,在本實施方式中,支撐機構20是一種下部開放並設置了為了引導可動支架30而沿移動方向延伸的作為筒狀插入孔的支架引導通道21的外套(housing)形狀。 在本實施方式中,支撐機構20的側壁23使可動支架30的向接觸頭10的接近方向的移動(前進移動)停止。即,對滑動(slide)移動的終點進行了規定。另外,在支撐機構20的側壁23上,固定了引導棒51的前端和連接棒53的前端。具體而言,在側壁23上,設置了固定引導棒51的側壁固定部23G和固定連接棒53的側壁固定部23J(參照圖5)。側壁固定部23G、23J如圖5所示也可包括緊固引導棒51、連接棒53的緊固部件或進行接著的接著部件等。 需要說明的是,形成支架引導通道的筒狀外套(housing)也可為上方開放(即,也可不設置上表面蓋部24)。例如,在本實施方式中,支撐機構20最低限度只要具有將可動支架30的一部分(保持針部的部分)向接觸頭10進行移動引導的移動引導軌22和成為對移動的末端進行規定的停止部的側壁23即可。 然而,如圖4(a)和圖4(c)所示,在本實施方式中,藉由設置上表面蓋部24,圓周面可引導可動支架30的前端,故,具有使移動更穩定的效果。此外/或者,還可考慮操作者的安全或衛生。 [內容物注入控制機構] 圖5中,(a)是本發明的內容物注入控制機構50的分解圖,(b)是內容物注入控制機構50和位於可動支架30的下表面的移動支撐部330的斷面圖。需要說明的是,圖5(b)相當於圖1(a)的B-B’面的斷面圖。 本發明的實施方式的注射裝置1具有作為內容物注入控制機構50的按壓部40、引導棒51、連動棒52、連接棒53、及線圈彈簧(第1彈性部件)54、55。 按壓部40向由可動支架30所保持的注射筒84內按壓活塞88。 引導棒51、連動棒52、及連接棒53是控制可動支架30的相對移動的棒狀部件。引導棒51可相對移動地與可動支架30和按壓部40進行卡合。 連動棒52緊固於可動支架30,並可移動地與按壓部40進行卡合。連接棒53延伸為與連動棒52相同的直線狀,其端部(後端)與連動棒52的端部(前端)相對以可進行接觸・分離。另外,連接棒53的前端位於可動支架30的內部。 此外,如圖5(b)所示,第1彈性部件(線圈彈簧)54、55設置在可動支架30的內部。 圖5(b)所示的可動支架30的下部表示設置在對注射筒84進行保持的部分的下部的移動支撐部330。 在移動支撐部330上,形成了引導棒51可滑動插入的第1貫穿孔331和前端可滑動插入連接棒53並且位於同一直線上的後端緊固連動棒52的第2貫穿孔332。 引導棒51和連接棒53可相對可動支架30的貫穿孔331、332分別進行移動。 另外,連動棒52藉由接著部件38在可動支架30的貫穿孔332內被固定在預定的位置。 可動支架30向接近接觸頭10的方向進行移動後,相對第1彈性部件,從引導棒51和連接棒53向可動支架30的內部所設置的線圈彈簧(第1彈性部件)54、55施加壓縮力。 按壓部40與引導棒51和連動棒52卡合。按壓部40是與活塞88的頭部(後端部)88h接觸並藉由相對移動壓入活塞88的活塞推壓部。藉由可動支架30上所設置的線圈彈簧54、55的回復力,可動支架30和接觸頭10之間的距離及可動支架30和按壓部40之間的距離進行變化。有關距離變化的細節,將基於圖8和圖9後述。 這裡,在可動支架30移動的距離為一定的情況下,施加在線圈彈簧54、55上的壓縮力為一定。故,在將預定量的內容物分割為多次且每次的注入量都相等的情況下,藉由使可動支架30的移動量為一定,線圈彈簧54、55的壓縮力及其之後的回復力也為一定,故,每次都可實施相同注入速度的注射動作。 在可動支架30的下部所設置的供棒狀部件51、52、53穿過的貫穿孔331、332的內壁上,作為彈簧保持部件,設置了突起36、37(即,貫穿孔331、332的直徑較小的部分)。 引導棒51和連接棒53上分別設置了小徑部和大徑部。小徑部51S、53S在引導棒51和連接棒53的延伸方向上位於可動支架30的中央附近,大徑部51F、53F位於可動支架30的支撐機構20側(前端側)。 線圈彈簧54、55外嵌在引導棒51、53的小徑部51S、53S上。外嵌了線圈彈簧54的導棒51內嵌於貫穿孔331。外嵌了線圈彈簧55的連接棒53和被固定了的連動棒52內嵌於貫穿孔332。 線圈彈簧(第1彈性部件)的前端保持在從引導棒51和連接棒53的大徑部51F、53F向小徑部51S、53S進行縮徑的側面(段差部分)上,後端保持在作為彈簧保持部件的突起36、37的突起側面36S、37S上。 需要說明的是,引導棒51和連接棒53為可進行分割的構成,以可使線圈彈簧54、55外嵌在小徑部51S、53S上。 在可動支架30的內部,就連接棒53而言,其末端的直徑較大,其末端的大徑端部53T可從其他部分切離,例如可藉由螺絲溝和螺絲溝等的嵌合進行緊固。這裡,就在突起37的按壓部40側的表面上連接棒53的末端的大徑端部53T和小徑部53S的段差進行接觸並卡合的位置而言,其為可動支架30和支撐機構20之間的距離最離開(最遠)的位置。 另外,在引導棒51中,就按壓部40側而言,較佳為設計成接近貫穿孔331的直徑的大小且大於小徑部51S(即,設置中徑部51M)。其原因在於,當為了使針管83移動而在線圈彈簧54、55上施加壓縮力時和彈簧回復時,即使後述的棘輪機構的卡合的嚙合方法變更了,中徑部51M也可沿貫穿孔332進行移動,故,可使支撐機構20相對引導棒51進行更順利的相對移動。 這裡,可動支架30從支撐機構20離開的距離D2(後述的距離Dm )與穿刺開始前的連動棒5和連接棒53之間距離D1相對應。藉由該距離,可設定注射針的注射深度。 這裡,注射針81的針管83的注射深度較佳位於0.5~5.5mm的範圍內,優選位於2.0mm~3.5mm的範圍內。 [按壓部] 圖6是按壓部40中的棘輪機構的說明圖。具體而言,是按壓部40的分解圖。 在引導棒51和連動棒52中,可在與按壓部40相對的部分的圓周面上,形成了帶有傾斜的卡合齒條(rack)51r、52r。 按壓部40具有與引導棒51和連動棒52的卡合齒條進行嚙合的制動器(板彈簧)41。需要說明的是,在按壓部40上,除了制動器之外,還設置了其上固定了制動器41的板彈簧支撐棒42和覆蓋制動器41的箱部44。板彈簧支撐棒42可移動自由地安裝在固定於按壓部40的支撐板45上。另外,在制動器41被固定的相反側,還設置了按鈕42h,按鈕42h和支撐板之間外嵌有壓縮線圈彈簧43。 這裡,按壓部40內的制動器41和引導棒51及連動棒52的卡合齒條51r、52r之間的卡合構成為棘輪機構。即,按壓部40可相對引導棒51和連動棒52向接近可動支架30的方向相對移動,而從可動支架30向遠離的方向即向分離方向(後退方向)的相對移動則被鎖住。 在注射器80的安裝、著脫時等對按壓部40的位置的鎖定進行解除的情況下,藉由抵抗線圈彈簧43而按壓按鈕42h,制動器41和卡合齒條51r、52r之間的卡合可被解除。具體將基於圖8和圖9後述。 [接觸頭] 圖7是接觸頭10的放大圖。如圖7所示,接觸頭10具有上表面13、側面14、及下表面12。接觸頭10的上表面13和下表面12的形狀為圓形、馬蹄形、多邊形形狀。 參照圖7(a)~(c),開口部11貫穿接觸頭10的上表面13和下表面12。另外,針可穿過開口部11。即,接觸頭10的開口部11相對接觸頭10的下表面12沿隨可動支架30的移動針管83進行穿過的方向和接觸頭10的上下方向的兩叉(‎bifurcated)方向進行了貫穿。 參照圖7(a)的側面斷面圖,在接觸頭10的下表面12上,開口部11的周邊的表面12c被構成為相對其他的下表面(例如,下表面突起12e)位於內側。這樣地構成下表面12後,在向被檢體注入內容物時,下表面12可與被檢體進行部分接觸,而開口部11的周邊則會變為與被檢體非接觸。 例如,作為變為非接觸的情況,在圖7(c)所示的實施方式中,在作為圓形的接觸頭10的下表面的緣部的圓周部上,形成了連續地沿下表面的表面方向突出的下表面突起12e。圓周形狀的下表面突起12e的頂部以包圍開口部11的周圍的方式與被檢體接觸。需要說明的是,下表面突起12e並不限定於連續的形狀,也可為腳形形狀等斷續的形狀。 藉由這樣地構成接觸頭10的下表面12,開口部11的周邊和被檢體之間變為可設定預定的空間。故,隨注射動作而從被檢體流出漏液或血液等液體時,藉由液體與接觸頭10的開口部11的周邊的下表面接觸,可抑制液體在下表面12上大面積附著。 此外,穿刺動作前和拔針動作後,針管83的前端被構成為位於比接觸頭10的下表面12的與被檢體接觸的部分還往上方的位置處。 具體而言,就適用於本發明的注射裝置的注射器的針管83而言,在穿刺前的階段,選擇使用針管83的長度,以使針管83的前端位於比接觸頭10的下表面的與被檢體接觸的部分還往上方的位置處。 例如,注射容量可在其他注射深度的每個其他注射部位處不同。注射長度的範圍可決定注射針的後退動作中的注射路徑的長度。故,注射全長可根據注射針的長度進行預定。注射針的注射全長較佳為2.0mm~50mm,優選為位於5.0mm~40mm的範圍內。 藉由這樣地在穿刺動作前和拔針動作後使注射針81的針管83的前端不與被檢體接觸,當該注射裝置離開被檢體時,在針管83刺入了被檢體的狀態下,可防止向非預期方向移動。故,可提高注射裝置的安全性。 此外,為了在操作中提高操作時與被檢體接觸的穩定性,並增大開口部11和被檢體之間的非接觸的空間,在接觸頭10的下表面12上,也可設置從側面14突出的凸緣部16。 參照圖7(b),開口部11是在上表面上從與注入點對應的位置開始朝向支撐機構20細長地進行延伸並開口的長孔形狀。 這樣,藉由將從上方觀察的開口部11的形狀如上所述構成為長孔形狀,在實施注射動作時,不僅可使注入方向明確化,而且還可使實施注射動作的操作者可對針管進行視認的時間變長。藉由使注入方向明確化,可相對目標注入點在更正確的位置實施注入動作。另外,藉由使針管的可視認時間變長,即使在針管83發生了彎曲或折斷等異常的情況下,進行注射動作之前也可發現之。故,可事先防止對被檢體所實施的異常注射動作。 此外,在接觸頭10的下表面12上,作為開口部11,在隨著注射針的上述移動的針管83的穿過方向上,設置了從貫穿上下方向的部分開始朝向支撐機構20並到達接觸頭10的下表面12的緣部的切口形狀。另外,在支撐機構20的下部,2個移動引導軌22之間開放,並設置了切口形狀。這樣,藉由使支撐機構20和接觸頭10的下方開放,可避免注射器80著脫時針管83與任一部分接觸。 另外,在本實施方式中,就接觸頭10的上表面13而言,為了構成放大鏡,較佳為研缽(mortar)形狀或凹向內側的半圓形狀等形狀。藉由放大鏡構成上表面後,可容易對注射部位進行可視化。例如,即使在由於光源的影響等難以直接進行視認的情況下,藉由利用放大鏡,也可一邊對開口部11和穿過開口部11的針管83進行視認,一邊進行注射。 為了使上述放大鏡的效果更好,在上表面上,與開口部11的注入點對應的位置較佳為下表面(上表面)的中心。此外,即使開口部11為長孔,為了容易識別注入點,還可在中心附近處設置記號17。 另外,在接觸頭10的側面14上,形成了作為定位溝15的線狀切口。該線狀切口用於在後述的注射準備階段對被檢體上的記號進行視認。藉由使側面14上所形成的作為用於對記號進行視認的切口的定位溝15為線狀,可容易地使後述實施步驟中所示的記號和接觸頭10的位置對齊。此外,切口為直線形狀,還具有容易進行表面加工的優點。 [注射動作] 圖8是第1實施方式的注射裝置1中的動作的說明圖。圖9是第1實施方式中的注射動作流程的說明圖。以下使用圖8和圖9對第1實施方式中的注射動作進行說明。 在本實施方式中,內容物注入控制機構50進行控制,以使內容物注入被檢體的同時,進行使針管83從預期深度後退至被檢體表面的拔針。以下對流程進行說明。 開始(START):將充填了注入液的注射器安置在注射裝置上。此時,進行至開始位置的設定,以使活塞88和按壓部40接觸(參照後述的實施步驟)。 作為前提,開始時,使注射裝置1的接觸頭10與被檢體S接觸。在穿刺動作前,假設該注射裝置1的各構成要素處於圖8(a)的狀態。需要說明的是,藉由上述圖7(a)所示的接觸頭10的下表面的形狀,在穿刺前的階段,針管83的前端位於比接觸頭10的下表面的與被檢體接觸的部分還往上方的位置處,故,針管83的前端不會與被檢體接觸。 S1:操作者手動地使可動支架30接近接觸頭10(穿刺動作)。此時,藉由使可動支架30向接近接觸頭10的方向(箭頭所示方向)進行移動,注射針81的針管83接近被檢體,向被檢體進行穿刺,並前進至被檢體的內部(進入)。這裡,可動支架30內所設置的線圈彈簧(第1彈性部件)54、55被進行壓縮。 具體而言,按壓部40與緊固在可動支架30上的連動棒52一起,在與可動支架30之間保持預定距離Dp 的同時,向接近接觸頭10的方向移動,距離Dm 變短(變為零)(圖8(a)⇒圖8(b))。這裡,由於與可動支架30緊固的連動棒52與可動支架30一起移動,故,按壓部40和連動棒52的末端也一起移動。 另外,由於按壓部40相對於不動的引導棒51進行移動,故,引導棒51和按壓部40的嵌合部分相對地向前進方向(可動支架30側)進行滑動。 藉由該按壓部40的相對移動,在穿刺動作中,可動支架30和按壓部40之間的距離不發生變化。故,藉由使可動支架30和按壓部40之間的距離變長,可防止只有活塞88後退的減壓所引起的氣泡的混入。此外,藉由使可動支架30和按壓部40之間的距離變短,還可防止實施與只有活塞88前進的穿刺動作並行的注入動作。 S2中,藉由使操作者的手離開可動支架30而向從接觸頭10的分離方向進行移動後,針管從被檢體的內部後退,從被檢體進行拔針,並從被檢體分離。 具體而言,賦予至可動支架30的前進方向的力釋放(消失)後,藉由可動支架30上所設置的線圈彈簧(第1彈性部件)54的回復力,可動支架30可從支撐機構20向分離方向進行移動。 這裡,按壓部40的相對棒狀部件51、52的向分離方向(後退方向)的相對移動藉由棘輪機構(圖6)被鎖定。即,可動支架30從接觸頭10向分離方向移動後,由於按壓部40與不動的未緊固的引導棒51一起停止,故,緊固在可動支架30上的連動棒52相對於不動的按壓部40進行位置移動。即,就按壓部40而言,相對於連動棒52,嵌合部分向可動支架30側(前進方向)進行滑動。 該動作使距離Dm 變長,並使距離Dp 變短,據此可同時進行拔針和液體注入(圖8(b)⇒(c))。伴隨可動支架30的後退動作,可動支架30相對引導棒51進行位置移動,據此可動支架30和按壓部40之間的距離變短。按壓部40和可動支架30之間的距離變短時(Dp ⇒Dp ’),活塞88相對注射筒84被壓入,注射筒84的容積變小,內部的液體可被注入被檢體。故,可恰當地實施適當量的注入動作。 結束(END):注射裝置1從被檢體離開。此時,藉由上述圖7(a)的接觸頭10的下表面的形狀,針管83的前端可從被檢體離開。 藉由上述構成和流程,本發明的注射裝置1在進行注入動作時,可動支架30中的注射筒84和注射針81可被適當地進行保持。尤其藉由凸緣嵌合部31和針基停止部33,內容物注入方向的注射筒84和注射針81的移動可被進行限制。 因此,在作為藉由注射而進行注入的內容物而採用黏性高的膠狀結構的物質的情況下,儘管使用時注射筒上的壓力較高,注射針和注射筒的連接狀態也不會解消。故,藉由注射裝置1,可實現精密的注射動作。 <第2實施方式> 接著對第2實施方式進行說明。第2實施方式的注射裝置較佳適用於針對被檢體的極淺的位置進行注射動作的情況。 在第2實施方式的注射裝置中,穿刺動作後,針的後退移動(拔針動作)分2個階段進行。具體而言,與基於活塞的向注射筒的按壓動作的注射動作(內容物射出動作)連動地進行針後退至預定距離的(拔針動作),之後,不進行注射動作,而是進行從該預定距離至從被檢體表面拔出為止的針的後退動作。 圖10是本發明的第2實施方式的注射裝置2的說明圖,(a)表示斜視圖,(b)表示側視圖。圖11是圖10的注射裝置的拔針控制機構的放大圖。圖12是圖10的注射裝置的透視斜視圖。 如圖10~圖12所示,本實施方式的注射裝置2具有拔針控制機構60。在本實施方式中,內容物注入控制機構50進行使內容物注入被檢體並同時使針管從預期深度後退至預定位置的第一階段的針管後退動作的控制。拔針控制機構60進行不使內容物注入被檢體地使針管從預定位置至少後退至被檢體表面並進行拔針的第二階段的針管後退動作。 參照圖11,拔針控制機構60具有控制板61、2個位置調整銷62、63、2個線圈彈簧(第2彈性部件)64、65、及鎖止銷66、67。 控制板61具有上表面板61T和側面板61S,其覆蓋支撐機構20-1的至少一部分的上表面部24-1和與接觸頭10分離的後端側的側壁23-1。 2個位置調整銷(銷釘)62、63具有大徑的頭部,並被嵌入控制板61的側面板61S。 作為第2彈性部件的線圈彈簧64、65設置(外嵌)於位置調整銷的外周,並被保持在控制板61的側面板61S和支撐機構20-1上。 2個鎖止銷(彈性銷)66、67設置在支撐機構20-1的上表面,一端被保持在可動支架30-1的圓周面保持部34-1的側面(引導面)。此外,鎖止銷66、67被設置為,沿與注射器80的移動方向大致垂直的方向(注射筒的短邊方向)延伸。 另外,在本實施方式中,在可動支架30-1的圓周面保持部34-1的上表面上,設置了卡合用突起39。卡合用突起39的前端部為前端較細的形狀,鎖止銷66、67與突起前端的垂直面(支架側引導面)39L、39M可滑動接觸。 支撐機構20-1具有上表面部24-1和側壁23-1,引導可動支架30-1的移動的引導路徑形成在內部。與第1實施方式同樣地,支撐機構20-1的側壁23-1被進行了開口(開口部23O),以可供可動支架30-1的一部分插入。 這裡,支撐機構20-1的形狀與第1實施方式不同,是用於在支撐機構20-1的上表面部24-1上嵌入控制板61的上表面板61T而凹陷的形狀的切口部26。鎖止銷66、67可與切口部26的移動方向的垂直面(支撐側引導面)27L、27M滑動接觸。 另外,還分別形成了相對垂直面27L、27M而凹陷的部分,即,切口空間變大的溝部28L、28M。 鎖止銷66、67為可伸縮的彈性銷,可沿可動支架30-1的支架側引導面39L、39M,及上表面板61T上所刻的溝61TL、61TM進行滑動移動。 進行注射動作時,在後述的圖13(a)的狀態下,支架側引導面39L、39M還未與鎖止銷66、67接觸。在此狀態下,可動支架30-1移動後,鎖止銷66、67開始與支架側引導面39L、39M的前端接觸,之後,沿支架側引導面39L、39M進行移動(圖11,左方向)。 接著,在即將變為圖13(b)的狀態時,藉由作為可動支架30的凸部的卡合用突起39的形狀,鎖止銷66、67向朝外的方向被壓出,與溝部28L、28M卡合(圖11(a)⇒圖11(b))。與溝部28L、28M卡合後,控制板61和可動支架30-1再進行移動,控制板61的上表面板61T的溝61TL、61TM相對鎖止銷66、67進行位置移動(圖13(b)⇒圖13(c))。 操作者的手離開後,首先,在鎖止銷66、67與溝部28L、28M卡合的狀態下,可動支架30-1進行移動(圖13(c)⇒圖13(d))。到達預定位置後,藉由作為可動支架30-1的凸部的卡合用突起39的支架側引導面39L、39M的形狀,賦予至鎖止銷66、67的向朝外的方向的按壓力消失,故,鎖止銷66、67和溝部28L、28M的卡合可被解除(圖11(b))。 接著,作為第2彈性部件的線圈彈簧64、65的回復力發生作用,藉此控制板61和可動支架30-1一起進行移動(圖11(b)⇒圖11(a),圖13(d)⇒13(e)),並完成後退動作。此時,卡合被解除了的鎖止銷66、67沿垂直面(支撐側引導面)27L、27M進行滑動。 另外,在本實施方式中,與第1實施方式不同,在支撐機構20-1的側壁23-1上,並沒有設置用於固定引導棒51、連接棒53的側壁固定部23G、23J。取而代之,開口了供外側嵌入了第2彈性部件64、65的位置調整銷62、63可移動地進行插入的銷插入孔23P、23Q。 控制板61的側面板61S被進行了開口,以供可動支架30-1的一部分插入。在本實施方式中,引導棒51-1的前端和連接棒53-2的前端固定在控制板61的側面板61S上。在側面板61S上,設置了固定引導棒51的側面固定部61SG和固定連動棒52的側面固定部61SJ(參照圖12)。 另外,在控制板61的側面板61S上,開口了側面板銷插入孔61SP、61SQ,以供外側嵌入了第2彈性部件64、65的位置調整銷62、63可移動地進行插入。 藉由穿刺動作,控制板61的側面板61S與支撐機構20-1的側壁23-1接觸。第一階段的針管後退動作中,在控制板61的側面板61S與支撐機構20-1的側壁23-1接觸了的狀態下,可動支架30-1進行後退。第二階段的針管後退動作中,控制板61的側面板61S從支撐機構20-1的側壁23-1離開,可動支架30-1進行後退。 [注射動作] 圖13是第2實施方式的注射動作的動作說明圖。圖15是第2實施方式的注射動作流程的說明圖。以下使用圖13和圖14對第2實施方式中的注射動作進行說明。 開始(START):作為前提,相對被檢體,使用注入用模板100(參照圖16)進行了注入點和記號的標記後,將注射器80(參照圖3)安置在注射裝置2上,並使注射裝置2的接觸頭10-1與被檢體接觸。 <針管前進動作> 圖14的S11中,操作者藉由手動使可動支架30-1接近接觸頭10(穿刺動作)。可動支架30-1向接近接觸頭10-1的方向移動預定距離後,相對第1彈性部件54、55,從引導棒51-1和連接棒53-2向第1彈性部件54、55施加壓縮力,並且,位置調整銷62、63與可動支架30-1一起向接近接觸頭10-1的方向進行移動。即,圖13中,距離DP 和距離DL 保持不變的同時,距離DM 變短(變為零),第1彈性部件54、55上被施加壓縮力(圖13(a)⇒(b))。 到達預定位置後,鎖止銷66、67與支撐機構20的溝部28L、28M卡合。 之後,在鎖止銷66,67與支撐機構20-1的溝部嵌合了的狀態下,位置調整銷62、63和控制板61向接觸頭10-1的方向(前進方向)進行移動。即,距離DM 為零保持不變的同時,距離DP 也保持不變,同時,距離DL 變短(變為零),第2彈性部件64、65上被施加壓縮力(圖13(b)⇒(c))。 <針管後退動作> 作為圖14的S12,操作者使手從可動支架30-1離開。可動支架30-1向接觸頭10-1的接近方向的力的施加消失後,作為第一階段,藉由第1彈性部件54、55的回復力,位置調整銷62、63和鎖止銷66、67的位置不變,可動支架30-1沿從支撐機構20-1離開並接近按壓部40的方向進行移動,據此將內容物注入被檢體,並且,使針管83從預期深度後退至預定位置。即,距離Dl保持不變的同時,距離DM 變長,距離DP 變短(DP ’),據此,可進行預定距離的後退和注入動作(圖13(c)⇒(d))。 作為圖14的S13的第2階段的後退動作,鎖止銷66、67脫離(從嵌合狀態被解放),位置調整銷62、63和控制板61的位置進行移動,據此,藉由第2彈性部件64、65的回復力,可動支架30-1、引導棒51、嵌合於接觸的連接棒53和連動棒52的按壓部40進行移動。即,距離DM 不變,距離DP ’保持不變的同時,距離DL 變長,據此,可不進行注入動作而使針管83從預定位置後退至可從被檢體拔針為止(圖13(d)⇒(e))。 藉由上述構成和流程,本發明的注射裝置2在進行注入動作時,可動支架30-1中的注射筒84和注射針81被適當地進行了保持。尤其藉由凸緣嵌合部31和針基停止部33,內容物注入時的移動方向的注射筒84和注射針81的位移被進行了限制。 因此,在作為藉由注射進行注入的內容物而採用了黏性高的膠狀結構的物質的情況下,儘管使用時注射筒上的壓力較高,注射針81和注射筒84的連接狀態也不會被解消。故,藉由注射裝置2,可實現精密的注射動作。 此外,在本實施方式中,由於分兩階段進行後退,故,可在注入動作結束後進行拔針。因此,在被檢體的極淺的位置處注入細胞等的微量且貴重的內容物的情況下,可實施所注入了的內容物不會從被檢體的表面溢出的注射動作。 [應用步驟] 為了確定注入部位或注入方向,注入前,使注入用模板100的中央的孔與注入部位的中心對齊(圖15(b)),並與6個縱長的孔對齊地使用殺菌後的油性筆做記號(圖15(c))。在同一部位不進行有間隔的反覆注入的情況下,使用化妝用染料等,對注入部位做記號。在向頭皮等有毛部位進行注入的情況下,事先對注入部位的周圍進行刮毛。注入前,對注入部位周邊進行消毒和乾燥後,進行麻醉。 將注射器80從包裝中取出,並將注入溶液充填至注射筒85內部。為了將注射器80安置在注射裝置1上,對按壓部40的後端的按鈕42h進行按壓,使其滑動至與接觸頭10相反的一側的最後端(圖16(a))。 就內含試驗製劑並連接了注射針81和活塞88的注射器80而言,一邊小心地以使針尖(針管的前端)不與注射裝置1的主體10、20等接觸,一邊將其安裝在注射裝置1的可動支架30上。具體而言,如圖16(b)所示,使注射器80從針尖斜著嵌入,並且使注射筒84的凸緣(翅膀)86立起並沿水平進行壓入(圖16(c)、(d))。接著,使凸緣86旋轉,以使其與凸緣嵌合部31咬合(圖16(e))。之後,使注射裝置1的按壓部40慢慢地移動至與活塞88的頭部88h接觸,以完成準備工作(圖16(f)、圖16(g))。 使用安裝了注射器80的注射裝置1(圖17(a)),使由殺菌後的油性筆所做的記號與接觸頭10的定位溝對齊。在此狀態下,將接觸頭10緊緊地按壓在頭皮上(圖17(b)、圖8的開始(START))。 在此狀態下,手動將可動支架30向接觸頭10側進行壓入,藉此與可動支架30一起移動的注射針81的針管83穿刺入頭皮內(相當於圖8的S1)。此時,藉由從上方對接觸頭10的中央部的長孔形狀的開口部11進行視認,可確認到針管83穿刺進了頭皮。 之後,藉由使手從注射裝置1的可動支架30上慢慢地離開,製劑被注入頭皮內(相當於圖8的S2)。接著,注入動作結束後,使注射裝置1從頭皮離開(相當於圖8的結束(END))。 在從同一注入部位沿不同方向進行多次注入的情況下,沿其他方向使皮膚上的油性筆的記號和接觸頭10周圍所設置的溝15對齊,並反覆實施上述注入操作。藉由在作為注入用記號的6個位置處反覆進行這樣的操作,在使用1mL的注射筒的情況下,可注入合計1.0mL的試驗製劑。 就使用後的注射裝置而言,卸下注射筒84和注射針81並進行廢棄後,進行洗淨和維護,並使用其他殺菌包進行捆包殺菌。殺菌可使用壓熱器(autoclave)、EO氣體(gas)、伽瑪線殺菌等的任一者。 這裡,藉由上述的構成,在進行注射動作的期間,在注射裝置1、2中,由於注射筒84和注射針81的連接狀態被進行了維持,故,可認為內容物基本上不會洩露至注射裝置1、2的內部。因此,清洗或殺菌步驟只要重點對接觸頭10的下表面12實施即可,與可預料到注射筒的著脫的先前例子的注射裝置相比,可基本上不用考慮安裝了注射器的注射裝置的內部的污染。 就上述的本發明的實施方式的注射裝置中所用的內容物(物質)而言,可從由細胞懸濁液、膠狀材料、治療用物質、美容用物質、及診斷用物質所構成的群中進行選擇。例如,就上述注射裝置中所用的內容物(物質)而言,可從由細胞懸濁液、膠狀材料、治療用物質、美容用物質、及診斷用物質所構成的群中進行選擇。 作為要注入的美容用物質,可包括填充物(filler)那樣的脂肪細胞、透明質酸(hyaluronic acid)、或皺紋治療用的肉毒桿菌毒素(botulinum toxin)(Botox、Btx)等,但並不限定於此。治療用物質可包括抗生物質、麻醉藥、鎮痛藥、疫苗、抗體,但並不限定於此。 另外,為了將作為注射器內所收藏的內容物的懸濁液內的細胞或液體介質內的細胞注入受實驗者,也可使用本發明的注射裝置。 此外,作為注射器內所收藏的內容物,細胞懸濁液還可與發育因子混合。或者,細胞懸濁液也可包括膠狀結構。這樣的膠狀結構較佳為表示模仿其他組織的細胞外環境的細胞外基質蛋白質的混合,優選為透明質酸那樣的膠狀結構。 另外,為了向受實驗者的其他組織內注入物質,也可使用本發明的實施方式的注射裝置。尤其是在掉頭髮、禿頂那樣的脫毛症或與頭髮欠缺或過少有關的其他症狀的治療中,可在進行作為細胞懸濁液的向皮膚內的細胞的注入時使用注射裝置。 此外,本發明的注射裝置較佳用於將藥劑、細胞活素(cytokine)、或發育因子那樣的液體注入受實驗者。向受實驗者的液體的該應用優選為關於掉頭髮、禿頂那樣的脫毛症或與頭髮欠缺或過少有關的其他症狀的治療而被執行。 或者,本發明的實施方式的注射裝置還可用於向受實驗者的筋肉注入物質或向受實驗者的筋腱注入物質。 另外,作為應用本發明實施方式的注射裝置的被檢體,並不限定於人(被檢者),也可為魚、鼠等動物。或者,被檢體還可為從受實驗者或受實驗對象動物上所提取出的皮膚、臟器等組織。 以上對本發明的較佳實施方式進行了詳述,然而本發明並不限定於上述特定的實施方式,在請求專利範圍內記載的本發明的要旨的範圍內,還可進行各種各樣的變形・變更。FIG. 1 is an explanatory diagram of an injection device according to a first embodiment of the present application. (a) is a schematic view and (b) is a side view. [Overall Description] The injection device 1 is an injection device for attaching a syringe that injects a content including a substance such as a cell suspension into a subject (human, animal, individual organ, skin, etc.). The injection device 1 functions as an injection syringe holder (injector holder) for injecting an appropriate amount of the contents into the subject using a syringe. The injection device has a contact head 10, a support mechanism 20, a movable bracket 30, and a content injection control mechanism 50. The contact head 10 is in contact with the subject and forms an opening. The contact head 10 is located at the front end of the injection device 1. When the needle tube 83 to be described later performs a puncture operation and a needle extraction operation with respect to the subject, the needle portion 83 passes through the opening portion 11 (see FIG. 4(b)). The support mechanism 20 is fixed to the contact head 10 at a predetermined angle. By the joint angle of the support mechanism 20 and the contact head 10, the injection angle with respect to the subject can be set. The contact head 10 and the support mechanism 20 may be integrally manufactured, or may be separately manufactured and then fixed by welding or the like. The support mechanism 20 is a bracket receiving portion that blocks the movable bracket 30 by specifying a stop position of the movement of the movable bracket 30. The movable holder 30 holds the syringe 84 and the injection needle 81 (refer to FIG. 2(a)), and is movable along the support mechanism 20 with respect to the contact head 10. By moving the movable holder 30 relative to the contact head 10, the syringe 84 and the injection needle 81 held by the movable holder 30 can be moved relative to the subject in contact with the contact head 10. By this relative movement, the needle tube 83 of the syringe 80 is movable relative to the subject in the advancing direction as the puncture direction and the retreating direction as the needle pulling direction. The contents injection control mechanism 50 presses the piston 88 against the syringe 84. The content injection control mechanism includes a pressing portion 40, a guide bar 51, a linkage bar 52, a connecting rod 53, and elastic members 54, 55 (see Fig. 5). Here, in the injection device 1 of the present invention, the syringe and the injection needle serve as a syringe, and can be detached. Fig. 2 is an explanatory view of a syringe, (a) showing the assembled syringe, and (b) showing an exploded view of the syringe. As shown in FIG. 2, the syringe 80 is composed of an injection needle 81, a syringe 84, and a piston 88. A cylinder 84 collects the contents in which the piston 88 is inserted. Specifically, the syringe 84 has an outer tubular portion 85 that houses the contents, a flange 86 that is provided at the rear end of the outer tubular portion 85, and a tubular front end 87. Here, in the injection device of the present invention, a syringe having a volume of 1 mL is preferably used. Such a 1 mL syringe can perform 10 100 μL injections or 6 166 μL injections. A syringe with 2, 5 or 10 mL can also be used. The syringe may also have a larger or smaller volume based on the particular form of use of the injection device. The injection needle 81 is connected to the syringe 84. Specifically, the injection needle 81 has a needle base 82 that is externally fitted to the barrel distal end 87 of the syringe 84, and a needle tube 83 that is punctured into the subject. When the syringe 80 is placed, the barrel leading end 87 of the syringe 84 is inserted into the needle base 82 of the injection needle 81 and engaged. A syringe having a structure by which the needle base 82 of the injection needle 81 and the barrel leading end 87 of the syringe 84 are not easily detached can also be used. Here, the diameter of the needle tube of the injection needle applied to the injection device of the present invention is preferably in the range of 18 to 34 G and 20 to 30 G. Further, it is preferably 26G, 27G or 30G. The piston 88 is pressed by the head (rear) 88h to move in the outer tubular portion 85 of the syringe 84, so that the contents can be discharged from the syringe. At the front end portion of the piston 88, a gasket 89 as a packing (sealing member) for preventing leakage of liquid or foreign matter is prevented. Here, in the present invention, the syringe 84 and the injection needle 81 shown in Fig. 2(a) are integrated and can be detached together, so that the contents stored in the syringe 84 are not attached to the injection device 1. The inside or the attachment is extremely small, whereby the injection device 1 can be reused. Here, the syringe 84 and the injection needle 81 may be integrated by at least when the injection device 1 is brought into and out of the injection device 1, and when it is installed outside the injection device 1, the syringe 84 and the injection are placed. The needles 81 may be in a state of being separated from each other. [Moving Support (Syringe Holder)] FIG. 3 is an enlarged cross-sectional view showing the upper surface of the movable holder 30. (a) is a perspective view, and (b) is a cross-sectional plan view taken along A-A' of (a). The movable bracket 30 has a syringe holder formed of a front bracket 310 and a rear bracket 320 at the upper portion, and a movable support that forms two through holes (331, 332, see FIG. 5) through which the rod-shaped members 51, 52, 53 pass. Part 330. Further, the coil springs 54 and 55 as the first elastic members are provided inside the movement support portion 330. The upper portions 310 and 320 of the movable holder have a flange fitting portion 31, an outer tubular portion holding portion 32, a needle base stopper 33, and a circumferential surface holding portion 34. The flange fitting portion 31 is fitted to the flange 86 of the syringe 84. As shown in FIG. 3(b), the flange fitting portion 31 has an outer frame shape of a wing shape in a plan view, and is engaged with the flange 86 by fitting the flange 86 into the outer frame shape. By this engagement, the flange 86 is positioned, thereby restricting the movement of the flange 86 relative to the movable holder 30 in the separation direction (reverse direction, the direction of the arrow B in Fig. 1(b)). The outer tubular portion holding portion 32 holds and holds the position of the outer tubular portion 85 of the syringe 84 from both sides. The outer tubular portion holding portion 32 has a linear rib shape that rises in a rib shape so as to extend along both sides of the side surface of the cylindrical outer tubular portion 85. With this configuration, the outer tubular portion holding portion 32 restricts the displacement in the lateral direction of the outer tubular portion 85 of the movable bracket 30, that is, the offset to the side surface. Even if the movable holder 30 moves, the holding state can be stably maintained. The needle base stop portion 33 limits the movement of the needle base 82 of the injection needle 81. In the example of the syringe shown in Fig. 2, the front end of the needle base 82 has a predetermined planar shape, and the needle base stop portion 33 shown in Fig. 3 is reduced in diameter by the inner diameter (a step is set), and the needle base 82 can be used. Front end face contact. In Fig. 3(a), the needle base stop portion 33 extends vertically in a direction in which it is stopped with respect to the moving direction of the syringe 80, and although the needle tube 83 can pass therethrough, it is a front end of the needle base 82 (perpendicular to the moving direction). The surface of the syringe 80 is in contact with the needle base stop portion 33, thereby restricting the movement of the syringe 80 relative to the movable holder 30. It should be noted that the needle base stopping portion 33 may not be perpendicular to the direction in which the syringe 80 is stopped in the moving direction. For example, the needle base 82 may be stopped by decreasing the shape of the circumference. Alternatively, in the case where the front end of the needle base 82 does not have a vertical surface, and the shape of the needle base 82 is gradually thickened toward the portion connected to the syringe barrel 8 (the needle base 82), the needle base stop portion 33 can also be used. Contact with the side of the needle base 82 limits the movement of the relative movable bracket 30 of the syringe 80. With this configuration, when the syringe 80 is attached to the injection device 1 and during the injection operation, the needle base 82 faces the direction toward the opening portion 11 of the movable holder 30 (the advancing direction, the arrow A of FIG. 1(b) The movement of the direction is limited. The circumferential surface holding portion (needle base circumferential surface holding portion) 34 holds the circumferential surface of the needle base 82 of the injection needle 81 in a circumferential surface shape. It should be noted that the circumferential surface holding portion 34 can also hold the front end of the outer tubular portion 85 of the syringe 84 in a circumferential shape. The circumferential surface holding portion 34 shown in FIG. 3 has a cylindrical shape that covers the entire circumferential surface in the circumferential direction of the tip end of the needle base 82 and the outer tubular portion 85. In addition, the circumferential surface holding portion 34 may not cover the entire circumference, and may have a shape in which the shape of the tip end of the needle base 82 and the outer tubular portion 85 is semicircular. By the circumferential surface holding portion 34, the displacement of the needle base 82 and the lateral direction of the outer tubular portion of the movable holder 30 can be restricted. According to this configuration, when the movable holder 30 moves, it is possible to prevent the movement (offset) in the side direction (short side direction) in the holding state. As described above, in the movable holder 30, the flange fitting portion 31 restricts the movement in the separation direction of the syringe 84 (the backward direction of the arrow B in Fig. 1(b)), and the needle base stopping portion 33 restricts the injection needle 81. The movement of the approaching direction (the advancing direction of the arrow A of Fig. 1(b)), according to which, the combined state of the syringe 84 and the injection needle 81 can be maintained in the moving direction. Therefore, even if the syringe 84 and the injection needle 81 move together with the movable holder 30, it is possible to prevent the injection needle 81 from coming off the syringe 84 and causing the contents to leak into the injection device 1. It should be noted that the outer tubular portion holding portion 32 of the movable bracket 30 may not stand up along the entire portion of the outer tubular portion 85 of the syringe 80. As shown in FIG. 3(a), by providing the flat portion 35 in which a part of the projection of the outer tubular portion holding portion 32 is interrupted, the syringe 80 can be easily inserted into the movable holder 30, whereby the syringe 80 can be lifted and lowered. Operationality. [Support Mechanism] The support mechanism 20 will be described based on Fig. 4 and Fig. 1(b). 4(a) is a perspective view of the contact head 10 and the support mechanism 20, and (b) is a perspective view seen from another direction. (c) is an arrow view along the arrow from the direction in which the contact head 10 and the support mechanism 20 are injected. The contact head 10 and the support mechanism 20 function as a fixing member (main body) that does not move relative to the movable movable bracket 30. The support mechanism 20 is fixed relative to the contact head 10. By the connection angle of the contact head 10 and the support mechanism 20, the contact angle of the needle tube 83 of the syringe 80 with respect to the subject can be set. The angle between the support mechanism 20 for specifying the injection angle and the contact head 10 is preferably any one of 10 to 90 degrees, preferably in the range of 15 to 25 degrees. The support mechanism 20 has an upper surface cover portion 24 and side walls 23, and inside the support mechanism 20, a cylindrical holder guide passage (insertion through hole) 21 for guiding the movement of the movable holder 30 is formed. Here, on the side wall 23 located at the rear end of the support mechanism 20, an opening portion 23A into which the movable bracket 30 is inserted as an entrance of the insertion hole of the bracket guide passage 21 is formed. The lower portion of the holder guiding passage 21 that can move the movable holder 30 along the support mechanism 20 functions as a moving guide rail 22 that guides the movable holder 30 to move. Below the support mechanism 20, a slit (opening) 25 extending in the side direction (injection direction) is provided. By opening the lower portion, it is possible to prevent the distal end of the needle tube 83 from coming into contact with the inside of the injection device 1 when the syringe 80 is disengaged. In the present embodiment, the outer peripheral surface of the inner circumferential surface of the stent guide passage 21 that is inserted into the through hole of the cylindrical insertion end of the movable holder 30 for inserting the distal end of the movable holder 30 (at least the portion holding the injection needle 81) is inserted. In part, it is a shape along the shape of the front end (circumferential surface holding portion 34) of the movable holder 30. As shown in FIGS. 4(a) and 4(c), in the support mechanism 20, the upper side and the two side sides of the bracket guiding passage 21 are covered in a semicircular shape (semi-cylindrical shape). Specifically, the support mechanism 20 has an upper surface cover portion 24 that covers at least the portion of the injection needle 81 and the movable holder 30 that holds the injection needle 81 in the circumferential direction and on the side (the needle base stop portion 33 and the circumferential surface are held) Part 34). Therefore, in the present embodiment, the support mechanism 20 is a housing shape in which the lower portion is opened and the bracket guide passage 21 as a cylindrical insertion hole extending in the moving direction for guiding the movable bracket 30 is provided. In the present embodiment, the side wall 23 of the support mechanism 20 stops the movement (advance movement) of the movable holder 30 in the approaching direction of the contact head 10. That is, the end point of the slide movement is specified. Further, on the side wall 23 of the support mechanism 20, the front end of the guide bar 51 and the front end of the connecting rod 53 are fixed. Specifically, the side wall 23 is provided with a side wall fixing portion 23G that fixes the guide bar 51 and a side wall fixing portion 23J that fixes the connecting rod 53 (see FIG. 5). As shown in FIG. 5, the side wall fixing portions 23G and 23J may also include a fastening member for fastening the guide bar 51, the connecting rod 53, or a subsequent connecting member. It should be noted that the cylindrical casing forming the stent guiding passage may also be open upward (ie, the upper surface covering portion 24 may not be provided). For example, in the present embodiment, the support mechanism 20 has a movement guide rail 22 that guides a part of the movable holder 30 (portion holding the needle portion) to the contact head 10 and a predetermined stop for moving the end. The side wall 23 of the portion can be used. However, as shown in FIGS. 4(a) and 4(c), in the present embodiment, by providing the upper surface cover portion 24, the circumferential surface can guide the front end of the movable holder 30, so that the movement is more stable. effect. In addition, / or, consider the safety or hygiene of the operator. [Content Injection Control Mechanism] In FIG. 5, (a) is an exploded view of the content injection control mechanism 50 of the present invention, and (b) is a content injection control mechanism 50 and a movement support portion located on the lower surface of the movable holder 30. Sectional view of 330. It should be noted that Fig. 5(b) corresponds to a cross-sectional view taken along line BB' of Fig. 1(a). The injection device 1 according to the embodiment of the present invention includes a pressing portion 40 as a content injection control mechanism 50, a guide bar 51, a linkage bar 52, a connecting rod 53, and coil springs (first elastic members) 54, 55. The pressing portion 40 presses the piston 88 into the inside of the syringe 84 held by the movable holder 30. The guide bar 51, the interlocking bar 52, and the connecting rod 53 are rod-like members that control the relative movement of the movable holder 30. The guide bar 51 is engaged with the movable bracket 30 and the pressing portion 40 in a relatively movable manner. The interlocking bar 52 is fastened to the movable holder 30, and is movably engaged with the pressing portion 40. The connecting rod 53 extends in the same linear shape as the interlocking rod 52, and its end (rear end) faces the end (front end) of the interlocking rod 52 so as to be in contact with and separated. Further, the front end of the connecting rod 53 is located inside the movable bracket 30. Further, as shown in FIG. 5(b), the first elastic members (coil springs) 54, 55 are provided inside the movable holder 30. The lower portion of the movable holder 30 shown in FIG. 5(b) shows the movement support portion 330 provided at the lower portion of the portion that holds the syringe 84. In the moving support portion 330, a first through hole 331 into which the guide bar 51 is slidably inserted, and a second through hole 332 in which the front end is slidably inserted into the connecting rod 53 and which are located on the same straight line and fastened to the interlocking bar 52 are formed. The guide bar 51 and the connecting rod 53 are movable relative to the through holes 331, 332 of the movable holder 30, respectively. Further, the interlocking bar 52 is fixed at a predetermined position in the through hole 332 of the movable bracket 30 by the following member 38. After the movable holder 30 moves in the direction approaching the contact head 10, compression is applied to the coil springs (first elastic members) 54, 55 provided from the guide rod 51 and the connecting rod 53 to the inside of the movable holder 30 with respect to the first elastic member. force. The pressing portion 40 is engaged with the guide bar 51 and the interlocking bar 52. The pressing portion 40 is a piston pressing portion that comes into contact with the head portion (rear end portion) 88h of the piston 88 and is pressed into the piston 88 by relative movement. The distance between the movable bracket 30 and the contact head 10 and the distance between the movable bracket 30 and the pressing portion 40 are changed by the restoring force of the coil springs 54, 55 provided on the movable bracket 30. Details regarding the change in distance will be described later based on FIGS. 8 and 9. Here, when the distance by which the movable holder 30 moves is constant, the compressive force applied to the coil springs 54, 55 is constant. Therefore, when the predetermined amount of the content is divided into a plurality of times and the injection amount is equal each time, the compression force of the coil springs 54, 55 and the subsequent recovery thereof are made constant by the movement amount of the movable holder 30. The force is also constant, so the injection action of the same injection speed can be performed every time. On the inner wall of the through holes 331, 332 through which the rod-like members 51, 52, 53 are provided, which are provided at the lower portion of the movable holder 30, as the spring holding members, protrusions 36, 37 are provided (i.e., through holes 331, 332). The smaller part of the diameter). A small diameter portion and a large diameter portion are respectively provided on the guide bar 51 and the connecting rod 53. The small diameter portions 51S and 53S are located near the center of the movable holder 30 in the extending direction of the guide bar 51 and the connecting rod 53, and the large diameter portions 51F and 53F are located on the support mechanism 20 side (front end side) of the movable holder 30. The coil springs 54, 55 are externally fitted to the small diameter portions 51S, 53S of the guide bars 51, 53. A guide bar 51 to which the coil spring 54 is fitted is fitted in the through hole 331. The connecting rod 53 to which the coil spring 55 is fitted and the fixed interlocking rod 52 are fitted in the through hole 332. The tip end of the coil spring (first elastic member) is held on the side surface (segment portion) which is reduced in diameter from the large diameter portions 51F and 53F of the guide bar 51 and the connecting rod 53 to the small diameter portions 51S and 53S, and the rear end is held as The projections 36, 37 of the spring retaining members are on the protruding sides 36S, 37S. It should be noted that the guide bar 51 and the connecting rod 53 are configured to be divided so that the coil springs 54 and 55 can be externally fitted to the small diameter portions 51S and 53S. In the inside of the movable holder 30, the diameter of the distal end of the connecting rod 53 is large, and the large-diameter end portion 53T at the distal end thereof can be separated from the other portions, for example, by fitting of a screw groove and a screw groove. Fasten. Here, in the position on the side of the pressing portion 40 of the projection 37, the position of the large-diameter end portion 53T of the end of the connecting rod 53 and the step of the small-diameter portion 53S contact and engage, which is the movable bracket 30 and the supporting mechanism The distance between 20 is the most left (farthest) position. Further, in the guide bar 51, the side of the pressing portion 40 is preferably designed to be close to the diameter of the through hole 331 and larger than the small diameter portion 51S (that is, the intermediate diameter portion 51M is provided). This is because when the compression force is applied to the coil springs 54, 55 in order to move the needle tube 83 and the spring is restored, even if the engagement method of the engagement of the ratchet mechanism described later is changed, the intermediate diameter portion 51M can be along the through hole. The movement of 332 is performed so that the support mechanism 20 can be relatively smoothly moved relative to the guide bar 51. Here, the distance D2 of the movable bracket 30 from the support mechanism 20 (the distance D described later) m ) corresponds to the distance D1 between the interlocking rod 5 and the connecting rod 53 before the start of the puncture. By this distance, the injection depth of the injection needle can be set. Here, the injection depth of the needle tube 83 of the injection needle 81 is preferably in the range of 0.5 to 5.5 mm, preferably in the range of 2.0 mm to 3.5 mm. [Pressing Portion] FIG. 6 is an explanatory diagram of the ratchet mechanism in the pressing portion 40. Specifically, it is an exploded view of the pressing portion 40. In the guide bar 51 and the interlocking bar 52, the engaging racks 51r and 52r having inclinations are formed on the circumferential surface of the portion opposed to the pressing portion 40. The pressing portion 40 has a stopper (plate spring) 41 that meshes with the engagement bars 51 and the engagement racks of the interlocking bars 52. In addition, in addition to the brake, the pressing portion 40 is provided with a leaf spring support bar 42 to which the brake 41 is fixed, and a case portion 44 that covers the brake 41. The leaf spring support bar 42 is movably mounted on the support plate 45 fixed to the pressing portion 40. Further, on the opposite side to which the brake 41 is fixed, a button 42h is further provided, and a compression coil spring 43 is externally fitted between the button 42h and the support plate. Here, the engagement between the brake 41 in the pressing portion 40 and the engagement bars 51r and 52r of the guide bar 51 and the interlocking bar 52 is configured as a ratchet mechanism. That is, the pressing portion 40 is relatively movable in the direction toward the movable holder 30 with respect to the guide bar 51 and the interlocking bar 52, and the relative movement from the movable holder 30 in the direction away from the movable direction, that is, in the separating direction (reverse direction) is locked. When the lock of the position of the pressing portion 40 is released when the syringe 80 is attached or detached, the button 42h is pressed against the coil spring 43, and the engagement between the stopper 41 and the engaging racks 51r and 52r is performed. Can be lifted. Specifically, it will be described later based on FIGS. 8 and 9. [Contact Head] FIG. 7 is an enlarged view of the contact head 10. As shown in FIG. 7, the contact head 10 has an upper surface 13, a side surface 14, and a lower surface 12. The upper surface 13 and the lower surface 12 of the contact head 10 have a circular shape, a horseshoe shape, and a polygonal shape. Referring to FIGS. 7(a) to 7(c), the opening portion 11 penetrates the upper surface 13 and the lower surface 12 of the contact head 10. In addition, the needle can pass through the opening portion 11. That is, the opening portion 11 of the contact head 10 penetrates the lower surface 12 of the contact head 10 in a bifurcated direction in which the direction of the movement of the movable holder 30 through the needle tube 83 and the vertical direction of the contact head 10 are performed. Referring to a side cross-sectional view of Fig. 7(a), on the lower surface 12 of the contact head 10, the peripheral surface 12c of the opening portion 11 is formed to be located inside with respect to the other lower surface (for example, the lower surface projection 12e). When the lower surface 12 is configured as described above, when the content is injected into the subject, the lower surface 12 can partially contact the subject, and the periphery of the opening 11 becomes non-contact with the subject. For example, in the case of becoming non-contact, in the embodiment shown in FIG. 7(c), on the circumferential portion of the edge portion of the lower surface of the circular contact head 10, continuous formation along the lower surface is formed. The lower surface protrusion 12e protruding in the surface direction. The top of the circumferential-shaped lower surface protrusion 12e is in contact with the subject so as to surround the periphery of the opening portion 11. It should be noted that the lower surface protrusions 12e are not limited to a continuous shape, and may have a discontinuous shape such as a foot shape. By constituting the lower surface 12 of the contact head 10 in this manner, a predetermined space can be set between the periphery of the opening portion 11 and the subject. Therefore, when a liquid such as liquid leakage or blood flows out from the subject in accordance with the injection operation, the liquid is brought into contact with the lower surface of the periphery of the opening portion 11 of the contact head 10, whereby the liquid can be prevented from adhering to a large area on the lower surface 12. Further, before the puncturing operation and after the plucking operation, the distal end of the needle tube 83 is configured to be located above the portion of the lower surface 12 of the contact head 10 that is in contact with the subject. Specifically, in the needle tube 83 of the syringe suitable for the injection device of the present invention, the length of the needle tube 83 is selected to be used at a stage before the puncture so that the distal end of the needle tube 83 is located at a lower surface than the lower surface of the contact head 10. The part touched by the specimen is also at the upper position. For example, the injection volume can vary at each of the other injection sites of other injection depths. The range of injection lengths determines the length of the injection path in the retraction action of the injection needle. Therefore, the total length of the injection can be predetermined according to the length of the injection needle. The total injection length of the injection needle is preferably from 2.0 mm to 50 mm, preferably from 5.0 mm to 40 mm. By the state in which the distal end of the needle tube 83 of the injection needle 81 is not in contact with the subject before the puncturing operation and the detachment operation, when the injection device is separated from the subject, the subject of the subject is pierced in the needle tube 83. Underneath, it prevents movement in unexpected directions. Therefore, the safety of the injection device can be improved. Further, in order to improve the stability of contact with the subject during operation, and to increase the non-contact space between the opening portion 11 and the subject, the lower surface 12 of the contact head 10 may also be provided. The flange portion 16 of the side surface 14 protrudes. Referring to Fig. 7(b), the opening portion 11 has a long hole shape that is elongated and opened toward the support mechanism 20 from a position corresponding to the injection point on the upper surface. As described above, the shape of the opening portion 11 as viewed from above is formed into a long hole shape as described above, and when the injection operation is performed, not only the injection direction can be clarified, but also the operator who performs the injection operation can perform the needle tube. The time for visual recognition becomes longer. By clarifying the injection direction, the injection action can be performed at a more correct position relative to the target injection point. Further, by making the visible time of the needle tube long, even when the needle tube 83 is abnormally bent or broken, it can be found before the injection operation. Therefore, the abnormal injection action performed on the subject can be prevented in advance. Further, on the lower surface 12 of the contact head 10, as the opening portion 11, in the passing direction of the needle tube 83 with the above-described movement of the injection needle, the portion from the up-and-down direction is set toward the support mechanism 20 and reaches the contact. The shape of the slit of the edge of the lower surface 12 of the head 10. Further, in the lower portion of the support mechanism 20, the two moving guide rails 22 are opened and a slit shape is provided. Thus, by opening the lower side of the support mechanism 20 and the contact head 10, it is possible to prevent the syringe 80 from coming into contact with any portion when the syringe 80 is brought off. Further, in the present embodiment, in order to constitute the magnifying glass, the upper surface 13 of the contact head 10 is preferably in the shape of a mortar or a semicircular shape having a concave inner side. After the upper surface is formed by a magnifying glass, the injection site can be easily visualized. For example, even when it is difficult to directly recognize the light source due to the influence of the light source or the like, it is possible to perform the injection while viewing the opening portion 11 and the needle tube 83 passing through the opening portion 11 by using the magnifying glass. In order to make the effect of the above-described magnifying glass better, on the upper surface, the position corresponding to the injection point of the opening portion 11 is preferably the center of the lower surface (upper surface). Further, even if the opening portion 11 is a long hole, in order to easily recognize the injection point, the mark 17 can be provided near the center. Further, on the side surface 14 of the contact head 10, a linear slit as the positioning groove 15 is formed. This linear slit is used to visualize the mark on the subject at the injection preparation stage described later. By arranging the positioning grooves 15 formed as the slits for visually recognizing the marks formed on the side faces 14 in a line shape, the marks shown in the later-described embodiment can be easily aligned with the positions of the contact heads 10. Further, the slit has a linear shape and has an advantage that surface processing is easy. [Injection Operation] FIG. 8 is an explanatory diagram of an operation in the injection device 1 according to the first embodiment. FIG. 9 is an explanatory diagram of an injection operation flow in the first embodiment. The injection operation in the first embodiment will be described below with reference to Figs. 8 and 9 . In the present embodiment, the content injection control unit 50 performs control so that the contents are injected into the subject, and the needle removing of the needle tube 83 from the expected depth to the surface of the subject is performed. The process is described below. START: Place the syringe filled with the infusion solution on the injection device. At this time, the setting to the start position is performed so that the piston 88 and the pressing portion 40 are in contact with each other (refer to an implementation step to be described later). As a premise, at the beginning, the contact head 10 of the injection device 1 is brought into contact with the subject S. Before the puncture operation, it is assumed that each component of the injection device 1 is in the state of Fig. 8(a). It should be noted that, by the shape of the lower surface of the contact head 10 shown in Fig. 7(a), the tip end of the needle tube 83 is in contact with the subject than the lower surface of the contact head 10 at the stage before the puncture. The portion is also at the upper position, so that the front end of the needle tube 83 does not come into contact with the subject. S1: The operator manually brings the movable holder 30 close to the contact head 10 (puncture action). At this time, by moving the movable holder 30 in the direction (direction indicated by the arrow) close to the contact head 10, the needle tube 83 of the injection needle 81 approaches the subject, punctures the subject, and proceeds to the subject. Internal (enter). Here, the coil springs (first elastic members) 54, 55 provided in the movable holder 30 are compressed. Specifically, the pressing portion 40 is held at a predetermined distance D from the movable bracket 30 together with the interlocking bar 52 fastened to the movable bracket 30. p Simultaneously moving in the direction of approaching the contact head 10, the distance D m Shorten (becomes zero) (Fig. 8(a) ⇒ Fig. 8(b)). Here, since the interlocking bar 52 fastened to the movable bracket 30 moves together with the movable bracket 30, the end portions of the pressing portion 40 and the interlocking bar 52 also move together. Further, since the pressing portion 40 moves relative to the stationary guide bar 51, the fitting portion of the guide bar 51 and the pressing portion 40 relatively slides in the advancing direction (the movable bracket 30 side). By the relative movement of the pressing portion 40, the distance between the movable holder 30 and the pressing portion 40 does not change during the puncture operation. Therefore, by increasing the distance between the movable holder 30 and the pressing portion 40, it is possible to prevent the incorporation of air bubbles due to the decompression in which the piston 88 is retracted. Further, by shortening the distance between the movable holder 30 and the pressing portion 40, it is possible to prevent the injection operation from being performed in parallel with the puncture operation in which only the piston 88 advances. In S2, by moving the operator's hand away from the movable holder 30 and moving in the direction of separation from the contact head 10, the needle tube is retracted from the inside of the subject, the needle is pulled out from the subject, and separated from the subject. . Specifically, after the force applied to the forward direction of the movable holder 30 is released (disappeared), the movable holder 30 can be detached from the support mechanism 20 by the restoring force of the coil spring (first elastic member) 54 provided on the movable holder 30. Move in the direction of separation. Here, the relative movement of the opposing rod-like members 51, 52 of the pressing portion 40 in the separating direction (reverse direction) is locked by the ratchet mechanism (FIG. 6). That is, after the movable holder 30 is moved from the contact head 10 in the separating direction, since the pressing portion 40 is stopped together with the stationary unfastened guiding rod 51, the interlocking rod 52 fastened to the movable holder 30 is pressed against the immovable movement. The portion 40 performs positional movement. In other words, in the pressing portion 40, the fitting portion slides toward the movable holder 30 side (advancing direction) with respect to the interlocking rod 52. This action makes the distance D m Lengthen and make distance D p Shortening, according to which needle extraction and liquid injection can be performed simultaneously (Fig. 8(b)⇒(c)). With the retracting operation of the movable holder 30, the movable holder 30 is moved in position relative to the guide bar 51, whereby the distance between the movable holder 30 and the pressing portion 40 is shortened. When the distance between the pressing portion 40 and the movable bracket 30 becomes short (D p ⇒D p '), the piston 88 is pressed in with respect to the syringe 84, the volume of the syringe 84 becomes small, and the internal liquid can be injected into the subject. Therefore, an appropriate amount of injection operation can be appropriately performed. End (END): The injection device 1 is separated from the subject. At this time, the front end of the needle tube 83 can be separated from the subject by the shape of the lower surface of the contact head 10 of Fig. 7(a) described above. With the above configuration and flow, when the injection device 1 of the present invention performs the injection operation, the syringe 84 and the injection needle 81 in the movable holder 30 can be appropriately held. In particular, by the flange fitting portion 31 and the needle base stopping portion 33, the movement of the syringe 84 and the injection needle 81 in the content injecting direction can be restricted. Therefore, in the case of using a substance having a highly viscous gel-like structure as a content to be injected by injection, although the pressure on the syringe is high during use, the connection state of the injection needle and the syringe is not Undo. Therefore, the injection device 1 can achieve a precise injection operation. <Second Embodiment> Next, a second embodiment will be described. The injection device according to the second embodiment is preferably applied to an injection operation for an extremely shallow position of the subject. In the injection device according to the second embodiment, after the puncture operation, the backward movement (needle removal operation) of the needle is performed in two stages. Specifically, the needle is retracted to a predetermined distance (the needle pulling operation) in conjunction with the injection operation (content ejection operation) of the pressing operation of the piston to the syringe, and thereafter, the injection operation is performed without performing the injection operation. The predetermined distance is the retracting motion of the needle until it is pulled out from the surface of the subject. FIG. 10 is an explanatory view of the injection device 2 according to the second embodiment of the present invention, wherein (a) is a perspective view and (b) is a side view. Figure 11 is an enlarged view of the needle pulling control mechanism of the injection device of Figure 10 . Figure 12 is a perspective oblique view of the injection device of Figure 10. As shown in FIGS. 10 to 12, the injection device 2 of the present embodiment has a needle removing control mechanism 60. In the present embodiment, the content injection control means 50 performs control of the needle retracting operation of the first stage of injecting the contents into the subject while retracting the needle tube from the expected depth to the predetermined position. The needle removing control unit 60 performs a needle retracting operation in a second stage in which the needle tube is at least retracted from the predetermined position to the surface of the subject and the needle is removed without injecting the contents into the subject. Referring to Fig. 11, the needle pulling control mechanism 60 has a control plate 61, two position adjustment pins 62 and 63, two coil springs (second elastic members) 64 and 65, and lock pins 66 and 67. The control board 61 has an upper surface plate 61T and a side panel 61S covering an upper surface portion 24-1 of at least a portion of the support mechanism 20-1 and a side wall 23-1 on the rear end side separated from the contact head 10. The two position adjusting pins (pins) 62, 63 have a large-diameter head and are fitted into the side panel 61S of the control board 61. The coil springs 64 and 65 as the second elastic members are provided (embedded) on the outer circumference of the position adjustment pin, and are held by the side panel 61S of the control panel 61 and the support mechanism 20-1. Two lock pins (elastic pins) 66, 67 are provided on the upper surface of the support mechanism 20-1, and one end is held on the side surface (guide surface) of the circumferential surface holding portion 34-1 of the movable holder 30-1. Further, the lock pins 66, 67 are provided to extend in a direction substantially perpendicular to the moving direction of the syringe 80 (the short side direction of the syringe). Further, in the present embodiment, the engagement projection 39 is provided on the upper surface of the circumferential surface holding portion 34-1 of the movable holder 30-1. The front end portion of the engaging projection 39 has a tapered shape, and the lock pins 66 and 67 are slidably contacted with the vertical surfaces (the bracket side guide surfaces) 39L and 39M of the projection front end. The support mechanism 20-1 has an upper surface portion 24-1 and a side wall 23-1, and a guiding path for guiding the movement of the movable holder 30-1 is formed inside. Similarly to the first embodiment, the side wall 23-1 of the support mechanism 20-1 is opened (opening portion 23O) so as to be inserted into a part of the movable holder 30-1. Here, the shape of the support mechanism 20-1 is different from that of the first embodiment, and is a cutout portion 26 for recessing the upper surface plate 61T of the control plate 61 on the upper surface portion 24-1 of the support mechanism 20-1. . The lock pins 66, 67 are slidably contactable with the vertical faces (support side guide faces) 27L, 27M of the moving direction of the notch portion 26. Further, portions which are recessed with respect to the vertical faces 27L and 27M, that is, the groove portions 28L and 28M in which the slit spaces become large are formed, respectively. The lock pins 66 and 67 are telescopic elastic pins which are slidably movable along the bracket-side guide faces 39L and 39M of the movable holder 30-1 and the grooves 61TL and 61TM engraved on the upper surface plate 61T. When the injection operation is performed, the holder-side guide surfaces 39L and 39M are not in contact with the lock pins 66 and 67 in the state of FIG. 13( a ) to be described later. In this state, after the movable bracket 30-1 is moved, the lock pins 66 and 67 come into contact with the front ends of the bracket-side guide surfaces 39L and 39M, and then move along the bracket-side guide surfaces 39L and 39M (FIG. 11, left direction). ). Then, in the state of FIG. 13(b), the locking pins 66 and 67 are pushed out in the outward direction by the shape of the engaging projection 39 as the convex portion of the movable holder 30, and the groove portion 28L 28M engagement (Fig. 11(a) ⇒ Fig. 11(b)). After the groove portions 28L and 28M are engaged with each other, the control plate 61 and the movable holder 30-1 are moved again, and the grooves 61TL and 61TM of the upper surface plate 61T of the control plate 61 are moved relative to the lock pins 66 and 67 (Fig. 13 (b). ) Figure 13 (c)). After the operator's hand has left, first, the movable holder 30-1 is moved in a state where the lock pins 66 and 67 are engaged with the groove portions 28L and 28M (FIG. 13(c) and FIG. 13(d)). When the predetermined position is reached, the pressing force applied to the outward direction of the lock pins 66 and 67 is lost by the shape of the bracket-side guide surfaces 39L and 39M of the engaging projections 39 as the convex portions of the movable bracket 30-1. Therefore, the engagement of the lock pins 66, 67 and the groove portions 28L, 28M can be released (Fig. 11 (b)). Then, the restoring force of the coil springs 64 and 65 as the second elastic members acts, whereby the control plate 61 and the movable holder 30-1 move together (FIG. 11(b), FIG. 11(a), FIG. 13(d) ) ⇒ 13 (e)), and complete the retreat action. At this time, the lock pins 66 and 67 whose engagement is released slide along the vertical planes (support side guide surfaces) 27L and 27M. Further, in the present embodiment, unlike the first embodiment, the side wall fixing portions 23G and 23J for fixing the guide bar 51 and the connecting rod 53 are not provided on the side wall 23-1 of the support mechanism 20-1. Instead, the pin insertion holes 23P and 23Q into which the position adjusting pins 62 and 63 of the second elastic members 64 and 65 are fitted to the outside are movably inserted. The side panel 61S of the control board 61 is opened for insertion of a part of the movable holder 30-1. In the present embodiment, the front end of the guide bar 51-1 and the front end of the connecting rod 53-2 are fixed to the side panel 61S of the control board 61. On the side panel 61S, a side surface fixing portion 61SG that fixes the guide bar 51 and a side surface fixing portion 61SJ that fixes the interlocking bar 52 (see FIG. 12) are provided. Further, the side panel pin insertion holes 61SP and 61SQ are opened in the side panel 61S of the control panel 61 so that the position adjustment pins 62 and 63 in which the second elastic members 64 and 65 are fitted outside are movably inserted. The side panel 61S of the control panel 61 is in contact with the side wall 23-1 of the support mechanism 20-1 by the puncturing operation. In the needle retracting operation of the first stage, the movable bracket 30-1 is retracted in a state where the side panel 61S of the control panel 61 is in contact with the side wall 23-1 of the support mechanism 20-1. In the second stage of the needle retracting operation, the side panel 61S of the control panel 61 is separated from the side wall 23-1 of the support mechanism 20-1, and the movable bracket 30-1 is retracted. [Injection Operation] FIG. 13 is an operation explanatory diagram of the injection operation in the second embodiment. Fig. 15 is an explanatory diagram of an injection operation flow in the second embodiment. The injection operation in the second embodiment will be described below with reference to Figs. 13 and 14 . START (START): As a premise, the injection point and the mark are marked with the injection template 100 (see FIG. 16), and the syringe 80 (see FIG. 3) is placed on the injection device 2, and The contact head 10-1 of the injection device 2 is in contact with the subject. <Needle Tube Advancing Operation> In S11 of Fig. 14, the operator manually approaches the movable holder 30-1 to the contact head 10 (puncture operation). After the movable bracket 30-1 is moved by a predetermined distance in the direction approaching the contact head 10-1, compression is applied to the first elastic members 54, 55 from the guide bars 51-1 and the connecting bars 53-2 with respect to the first elastic members 54, 55. The force, and the position adjustment pins 62, 63 move together with the movable bracket 30-1 in the direction approaching the contact head 10-1. That is, in Figure 13, the distance D P And distance D L While maintaining the same distance, distance D M Shortening (zeroing), a compressive force is applied to the first elastic members 54, 55 (Fig. 13 (a) - (b)). When the predetermined position is reached, the lock pins 66, 67 are engaged with the groove portions 28L, 28M of the support mechanism 20. Thereafter, in a state in which the lock pins 66, 67 are fitted to the groove portion of the support mechanism 20-1, the position adjustment pins 62, 63 and the control plate 61 are moved in the direction (advancing direction) of the contact head 10-1. Ie, distance D M Distance zero while maintaining the same distance P Also remains the same, at the same time, distance D L Shortening (zeroing), a compressive force is applied to the second elastic members 64 and 65 (Fig. 13 (b) ⇒ (c)). <Needle Tube Retraction Operation> As S12 of Fig. 14, the operator separates the hand from the movable holder 30-1. After the application of the force of the movable bracket 30-1 in the approaching direction of the contact head 10-1 disappears, the position adjusting pins 62, 63 and the lock pin 66 are restored by the restoring forces of the first elastic members 54, 55 as the first stage. The position of 67 is unchanged, and the movable holder 30-1 moves in a direction away from the support mechanism 20-1 and close to the pressing portion 40, thereby injecting the contents into the subject, and retracting the needle 83 from the expected depth to Pre-determined location. That is, while the distance Dl remains the same, the distance D M Variable length, distance D P Shorter (D P ') According to this, the retreat and injection operation of the predetermined distance can be performed (Fig. 13 (c) ⇒ (d)). As a retreating operation of the second stage of S13 in Fig. 14, the lock pins 66 and 67 are disengaged (to be released from the fitted state), and the positions of the position adjustment pins 62 and 63 and the control board 61 are moved, whereby The restoring force of the elastic members 64 and 65 is moved by the movable holder 30-1, the guide rod 51, the connecting rod 53 fitted to the contact, and the pressing portion 40 of the interlocking rod 52. Ie, distance D M Constant, distance D P 'Keeping the same distance, distance D L According to this, the needle tube 83 can be retracted from the predetermined position to the position where the needle can be removed from the subject without performing the injection operation (Fig. 13 (d) - (e)). With the above configuration and flow, when the injection device 2 of the present invention performs the injection operation, the syringe 84 and the injection needle 81 in the movable holder 30-1 are appropriately held. In particular, by the flange fitting portion 31 and the needle base stopping portion 33, the displacement of the syringe 84 and the injection needle 81 in the moving direction at the time of content injection is restricted. Therefore, in the case of using a substance having a highly viscous gel-like structure as a content to be injected by injection, although the pressure on the syringe is high in use, the connection state of the injection needle 81 and the syringe 84 is also Will not be solved. Therefore, the injection device 2 can realize a precise injection operation. Further, in the present embodiment, since the retreat is performed in two stages, the needle can be pulled after the end of the injection operation. Therefore, when a small amount of valuable content such as cells is injected at a very shallow position of the subject, an injection operation in which the injected contents do not overflow from the surface of the subject can be performed. [Application Step] In order to determine the injection site or the injection direction, before the injection, the hole in the center of the injection template 100 is aligned with the center of the injection site (Fig. 15 (b)), and the sterilization is performed in alignment with the six longitudinal holes. The oily pen after the mark is made (Fig. 15(c)). When the same portion is not subjected to the intermittent injection, the injection site is marked with a cosmetic dye or the like. When injecting into a hairy part such as a scalp, the periphery of the injection site is shaved in advance. Before the injection, the periphery of the injection site is disinfected and dried, and anesthesia is performed. The syringe 80 is taken out of the package and the infusion solution is filled into the inside of the syringe 85. In order to place the syringe 80 on the injection device 1, the button 42h at the rear end of the pressing portion 40 is pressed to slide to the rearmost end on the side opposite to the contact head 10 (Fig. 16 (a)). With regard to the syringe 80 containing the test preparation and to which the injection needle 81 and the piston 88 are connected, the needle tip (the front end of the needle tube) is carefully placed in contact with the main body 10, 20 or the like of the injection device 1 while being carefully placed. On the movable bracket 30 of the device 1. Specifically, as shown in Fig. 16 (b), the syringe 80 is obliquely inserted from the needle tip, and the flange (wing) 86 of the syringe 84 is raised and pressed horizontally (Fig. 16(c), ( d)). Next, the flange 86 is rotated to be engaged with the flange fitting portion 31 (Fig. 16(e)). Thereafter, the pressing portion 40 of the injection device 1 is slowly moved to come into contact with the head portion 88h of the piston 88 to complete the preparation work (Fig. 16 (f), Fig. 16 (g)). Using the injection device 1 (Fig. 17 (a)) in which the syringe 80 is attached, the mark made by the sterilized oil pen is aligned with the positioning groove of the contact head 10. In this state, the contact head 10 is pressed tightly against the scalp (Fig. 17 (b), start (START) of Fig. 8). In this state, the movable holder 30 is manually pushed into the contact head 10 side, whereby the needle tube 83 of the injection needle 81 that moves together with the movable holder 30 is inserted into the scalp (corresponding to S1 of Fig. 8). At this time, it was confirmed that the needle tube 83 was punctured into the scalp by visually recognizing the long hole-shaped opening portion 11 at the center portion of the contact head 10 from above. Thereafter, by slowly withdrawing the hand from the movable holder 30 of the injection device 1, the preparation is injected into the scalp (corresponding to S2 of Fig. 8). Next, after the injection operation is completed, the injection device 1 is separated from the scalp (corresponding to the end (END) of FIG. 8). In the case where a plurality of injections are made in different directions from the same injection site, the marks of the oil-based pen on the skin are aligned with the grooves 15 provided around the contact head 10 in other directions, and the above-described injection operation is repeatedly performed. By repeating such an operation at six positions as injection symbols, when a 1 mL syringe is used, a total of 1.0 mL of the test preparation can be injected. In the injection device after use, the syringe 84 and the injection needle 81 are removed and discarded, and then washed and maintained, and packaged and sterilized using another sterilization bag. For sterilization, any of autoclave, EO gas, gamma sterilization, or the like can be used. Here, according to the above configuration, in the injection devices 1 and 2, since the connection state of the syringe 84 and the injection needle 81 is maintained, it is considered that the contents are substantially not leaked. To the inside of the injection devices 1, 2. Therefore, the cleaning or sterilizing step can be carried out as much as possible on the lower surface 12 of the contact head 10, and the injection device in which the syringe is mounted can be substantially ignored as compared with the injection device of the previous example in which the detachment of the syringe can be expected. Internal pollution. The content (substance) used in the injection device according to the embodiment of the present invention described above can be composed of a cell suspension, a gel material, a therapeutic substance, a cosmetic substance, and a diagnostic substance. Make a choice. For example, the content (substance) used in the above injection device can be selected from the group consisting of a cell suspension, a gel material, a therapeutic substance, a cosmetic substance, and a diagnostic substance. The cosmetic substance to be injected may include fat cells such as a filler, hyaluronic acid, or botulinum toxin (Botox, Btx) for wrinkle treatment, but It is not limited to this. The therapeutic substance may include antibiotics, anesthetics, analgesics, vaccines, and antibodies, but is not limited thereto. Further, the injection device of the present invention can also be used in order to inject cells in a suspension or a liquid medium in a suspension which is a content stored in a syringe into a subject. In addition, as a content stored in the syringe, the cell suspension can also be mixed with developmental factors. Alternatively, the cell suspension may also comprise a gelatinous structure. Such a gel-like structure is preferably a mixture of extracellular matrix proteins which mimic the extracellular environment of other tissues, and is preferably a gelatinous structure such as hyaluronic acid. Further, in order to inject a substance into other tissues of the subject, an injection device according to an embodiment of the present invention can also be used. In particular, in the treatment of hair loss such as hair loss or baldness or other symptoms associated with lack or lack of hair, an injection device can be used when injecting cells into the skin as a cell suspension. Further, the injection device of the present invention is preferably used for injecting a liquid such as a drug, a cytokine, or a development factor into a subject. This application of the liquid to the subject is preferably performed with respect to treatment for hair loss, baldness, or other symptoms associated with lack or lack of hair. Alternatively, the injection device of the embodiment of the present invention may be used to inject a substance into the muscle of the subject or to inject the substance into the tendon of the subject. In addition, the subject to which the injection device according to the embodiment of the present invention is applied is not limited to a person (subject), and may be an animal such as a fish or a mouse. Alternatively, the subject may be a tissue such as a skin or an organ extracted from an experimentee or an animal to be tested. The preferred embodiments of the present invention have been described in detail above. However, the present invention is not limited to the specific embodiments described above, and various modifications may be made within the scope of the gist of the invention described in the claims. change.

1、2‧‧‧注射裝置1, 2‧‧‧ injection device

10、10-1‧‧‧接觸頭10,10-1‧‧‧Contact head

11‧‧‧開口部11‧‧‧ openings

12‧‧‧下表面12‧‧‧ Lower surface

12c‧‧‧下表面中央部12c‧‧‧Central part of the lower surface

12e‧‧‧下表面突起12e‧‧‧ lower surface protrusion

13‧‧‧上表面13‧‧‧ upper surface

14‧‧‧側面14‧‧‧ side

15‧‧‧定位溝15‧‧‧Positioning trench

16‧‧‧凸緣部16‧‧‧Flange

17‧‧‧記號17‧‧‧ mark

20、20-1‧‧‧支撐機構20, 20-1‧‧‧Support institutions

21‧‧‧支架引導通道(插入孔)21‧‧‧ bracket guiding channel (insertion hole)

22‧‧‧移動引導軌22‧‧‧Mobile guide rail

23‧‧‧支撐機構的側壁23‧‧‧Sidewall of the support mechanism

23G、23J‧‧‧側壁固定部23G, 23J‧‧‧ sidewall fixing

23O‧‧‧開口部23O‧‧‧ Opening

23P、23Q‧‧‧銷插入孔23P, 23Q‧‧ ‧ pin insertion hole

24‧‧‧支撐機構的上表面蓋部24‧‧‧ Upper surface cover of the support mechanism

24-1‧‧‧支撐機構的上表面部24-1‧‧‧ Upper surface of the support mechanism

25‧‧‧支撐機構的下表面切口開口部25‧‧‧The lower surface opening of the support mechanism

26‧‧‧切口部26‧‧‧Incision Department

27L、27M‧‧‧垂直面(支撐側引導面)27L, 27M‧‧‧ vertical plane (support side guide surface)

28L、28M‧‧‧溝部28L, 28M‧‧‧ Ditch

30、30-1‧‧‧可動支架(holder)30, 30-1‧‧‧ movable bracket (holder)

31‧‧‧凸緣嵌合部31‧‧‧Flange fitting

32‧‧‧外筒部夾持部32‧‧‧Outer tube clamping

33‧‧‧針基停止部33‧‧‧ Needle-based stop

34‧‧‧圓周面保持部34‧‧‧Circumferential surface retention

34-1‧‧‧圓周面保持部34-1‧‧‧Circumferential surface retention

35‧‧‧平面部35‧‧‧Flat Department

36、37‧‧‧突起(彈簧保持部件)36, 37‧‧‧ protrusions (spring holding parts)

36S、37S‧‧‧突起側面36S, 37S‧‧‧ protruding side

38‧‧‧接著部件38‧‧‧Next parts

39‧‧‧卡合用突起39‧‧‧Clamping protrusion

39L、39M‧‧‧垂直面(支架側引導面)39L, 39M‧‧‧ vertical plane (support side guide surface)

40‧‧‧按壓部(注入控制機構)40‧‧‧ Pressing section (injection control mechanism)

41‧‧‧制動器(板彈簧)41‧‧‧Brake (plate spring)

42‧‧‧板彈簧支撐棒42‧‧‧Sheet spring support rod

42h‧‧‧按鈕42h‧‧‧ button

43‧‧‧按壓部彈簧43‧‧‧ Pressing spring

44‧‧‧上蓋44‧‧‧Upper cover

50‧‧‧內容物注入控制機構50‧‧‧Content injection control mechanism

51、51-1‧‧‧引導棒51, 51-1‧‧‧ Guide rod

51F‧‧‧大徑部51F‧‧‧Great Path Department

51M‧‧‧中徑部51M‧‧‧Medium Department

51r‧‧‧卡合齒條51r‧‧‧Kinematic rack

51S‧‧‧小徑部51S‧‧‧Little Trails Department

52‧‧‧連動棒52‧‧‧ linkage rod

52r‧‧‧卡合齒條52r‧‧‧Kinematic rack

53、53-1‧‧‧連接棒53, 53-1‧‧‧ Connecting rod

53F‧‧‧大徑部53F‧‧‧Great Path Department

53S‧‧‧小徑部53S‧‧‧Little Trails Department

53T‧‧‧連接棒的大徑的末端End of the large diameter of the 53T‧‧‧ connecting rod

54、55‧‧‧線圈彈簧(第1彈性部件)54, 55‧‧‧ coil spring (1st elastic part)

60‧‧‧控制機構60‧‧‧Control agency

61‧‧‧控制板61‧‧‧Control panel

61S‧‧‧控制板的側面板Side panel of 61S‧‧‧ control panel

61SG、61SJ‧‧‧側面板固定部61SG, 61SJ‧‧‧ side panel fixing

61SP、61SQ‧‧‧側面板銷插入孔61SP, 61SQ‧‧‧ side panel pin insertion hole

61T‧‧‧控制板的上表面板61T‧‧‧ upper surface plate of the control panel

61TL‧‧‧溝61TL‧‧‧Ditch

61TM‧‧‧溝61TM‧‧‧Ditch

62、63‧‧‧移動調整銷62, 63‧‧‧Mobile adjustment pin

64、65‧‧‧線圈彈簧(第2彈性部件)64, 65‧‧‧ coil spring (2nd elastic part)

66、67‧‧‧鎖止銷66, 67‧‧‧ lock pin

80‧‧‧注射器80‧‧‧Syringe

81‧‧‧注射針81‧‧‧Injection needle

82‧‧‧針基82‧‧‧ needle base

83‧‧‧針管83‧‧‧ needle

84‧‧‧注射器(syringe)84‧‧‧Syringe (syringe)

85‧‧‧外筒部85‧‧‧Outer tube

86‧‧‧凸緣86‧‧‧Flange

87‧‧‧筒前端87‧‧‧ tube front end

88‧‧‧活塞(plunger)88‧‧‧Piston

88h‧‧‧活塞頭部88h‧‧‧ piston head

89‧‧‧襯墊89‧‧‧ cushion

100‧‧‧注入用模板100‧‧‧Injection template

310‧‧‧前方支架310‧‧‧ front bracket

320‧‧‧後方支架320‧‧‧ rear bracket

330‧‧‧移動支撐部330‧‧‧Mobile support

331‧‧‧第1貫穿孔331‧‧‧1st through hole

332‧‧‧第2貫穿孔332‧‧‧2nd through hole

A‧‧‧前進方向A‧‧‧ Forward direction

B‧‧‧後退方向B‧‧‧Retreating direction

B-B’‧‧‧斷面方向B-B’‧‧‧ cross-section

DL‧‧‧距離D L ‧‧‧Distance

Dm‧‧‧距離D m ‧‧‧Distance

Dp‧‧‧預定距離D p ‧‧‧Predetermined distance

Dp’‧‧‧距離D p '‧‧‧Distance

[第1圖(a)、(b)]本發明第1實施方式的注射裝置的說明圖。 [第2圖(a)、(b)]適用於本發明的注射裝置的注射器的構成圖。 [第3圖(a)、(b)]圖1的注射裝置中的可動支架的說明圖。 [第4圖(a)~(d)]圖1的注射裝置中的可動支架和支撐機構的說明圖。 [第5圖(a)、(b)]位於圖4所示的可動支架下表面的移動機構和棒狀部件的說明圖。 [第6圖]圖1的注射裝置中的按壓部的棘輪(‎ratchet)機構的說明圖。 [第7圖(a)~(c)]圖1的注射裝置中的接觸頭的說明圖。 [第8圖(a)~(c)]本發明第1實施方式的注射裝置的動作說明圖。 [第9圖]第1實施方式的注射動作流程的說明圖。 [第10圖(a)、(b)]本發明第2實施方式的注射裝置。 [第11圖(a)、(b)]圖10的注射裝置的拔針控制機構的放大圖。 [第12圖]圖10的注射裝置的透視斜視圖。 [第13圖(a)~(e)]本發明第1實施方式的注射裝置的動作說明圖。 [第14圖]第2實施方式的注射動作流程的說明圖。 [第15圖(a)~(c)]使用注射用模板(‎template)對被檢體做記號時的說明圖。 [第16圖(a)~(g)]注射器的安裝步驟的說明圖。 [第17圖(a)、(b)]安裝了注射器的注射裝置和使注射裝置與被檢體接觸的圖。[Fig. 1 (a) and (b)] are explanatory views of an injection device according to a first embodiment of the present invention. [Fig. 2 (a), (b)] A configuration diagram of a syringe applied to the injection device of the present invention. [Fig. 3 (a) and (b)] are explanatory views of the movable holder in the injection device of Fig. 1. [Fig. 4 (a) to (d)] are explanatory views of the movable holder and the support mechanism in the injection device of Fig. 1. [Fig. 5 (a) and (b)] explanatory views of the moving mechanism and the rod member located on the lower surface of the movable holder shown in Fig. 4 . Fig. 6 is an explanatory view of a ratchet mechanism of a pressing portion in the injection device of Fig. 1. [Fig. 7 (a) to (c)] explanatory views of the contact head in the injection device of Fig. 1. [Fig. 8 (a) to (c)] FIG. 8 is a view explaining the operation of the injection device according to the first embodiment of the present invention. [Fig. 9] An explanatory diagram of an injection operation flow in the first embodiment. [Fig. 10 (a) and (b)] An injection device according to a second embodiment of the present invention. [Fig. 11 (a), (b)] An enlarged view of the needle removing control mechanism of the injection device of Fig. 10. [Fig. 12] A perspective oblique view of the injection device of Fig. 10. [Fig. 13 (a) to (e)] FIG. 13 is a view explaining the operation of the injection device according to the first embodiment of the present invention. [Fig. 14] An explanatory diagram of an injection operation flow in the second embodiment. [Fig. 15 (a) to (c)] explanatory diagrams when the subject is marked with an injection template. [Fig. 16 (a) to (g)] explanatory views of the mounting procedure of the syringe. [Fig. 17 (a), (b)] A syringe device in which a syringe is attached and a diagram in which the injection device is brought into contact with the subject.

Claims (23)

一種注射裝置,藉由具有活塞、插嵌該活塞的注射筒、及由與該注射筒連接的針基和向被檢體內穿刺的針管所構成的注射針之注射器,使內容物注入被檢體,該注射裝置的特徵在於,具有: 接觸頭,可與被檢體接觸,並形成了供該針管穿過的開口部; 可動支架,對該注射筒和該注射針進行保持; 支撐機構,固定在該接觸頭上;及 內容物注入控制機構,將該活塞壓入該注射筒的內部, 藉由該可動支架沿該支撐機構進行移動,使該注射筒和該注射針相對該接觸頭進行移動, 該注射器相對該注射裝置可進行著脫。An injection device for injecting a content into a sample by a syringe having a piston, a syringe into which the piston is inserted, and a needle connected to the syringe and a needle that is punctured into the subject The injection device is characterized in that it has: a contact head that can be in contact with the subject and forms an opening through which the needle tube passes; a movable bracket that holds the syringe and the injection needle; a support mechanism that fixes And the content injection control mechanism presses the piston into the interior of the syringe, and the movable bracket moves along the support mechanism to move the syringe and the injection needle relative to the contact head. The syringe is detachable relative to the injection device. 根據請求項1之注射裝置,其特徵在於, 該內容物注入控制機構具有將該活塞壓入該注射筒內的按壓部, 藉由該可動支架向接近該接觸頭的前進方向進行移動,使該針管穿刺被檢體,並進入被檢體的內部, 藉由該可動支架向離開該接觸頭的後退方向進行移動,一邊使該針管相對被檢體進行後退,一邊使該可動支架接近該按壓部,並將該活塞壓入該注射筒內,以將該內容物注入被檢體。The injection device according to claim 1, wherein the content injection control mechanism has a pressing portion that presses the piston into the syringe, and the movable holder moves toward a direction in which the contact head is moved, so that the The needle punctures the subject and enters the inside of the subject, and the movable holder moves in a backward direction away from the contact head, and the needle holder is moved back relative to the subject, and the movable holder is brought close to the pressing portion. And pressing the piston into the syringe to inject the contents into the subject. 根據請求項2之注射裝置,其特徵在於, 該注射筒具有收藏該內容物的外筒部和設置於該外筒部的後端的凸緣, 該可動支架具有藉由與該凸緣嵌合以進行保持的凸緣嵌合部,該凸緣嵌合部限制該凸緣相對該可動支架的向該後退方向的移動。An injection device according to claim 2, wherein the syringe has an outer tubular portion that houses the contents and a flange that is provided at a rear end of the outer tubular portion, the movable bracket having a fitting with the flange A flange fitting portion that holds the movement of the flange relative to the movable bracket in the backward direction. 根據請求項3之注射裝置,其特徵在於, 該可動支架具有藉由沿該外筒部的側部的兩側而立起的突起對該外筒部進行夾入並保持的外筒部夾持部,該外筒部夾持部限制該外筒部的相對該可動支架的側面方向的位移。The injection device according to claim 3, wherein the movable holder has an outer cylindrical portion sandwiching portion that sandwiches and holds the outer cylindrical portion by protrusions rising along both sides of the side portion of the outer tubular portion. The outer tubular portion holding portion restricts displacement of the outer tubular portion with respect to a side surface direction of the movable bracket. 根據請求項2之注射裝置,其特徵在於, 該可動支架具有藉由與該針基的前端付近接觸的突起而使該注射針的移動停止並進行保持的針基停止部,該針基停止部限制該針基的相對該可動支架的向該前進方向的移動。The injection device according to claim 2, wherein the movable holder has a needle base stopping portion that stops and holds the movement of the injection needle by a protrusion that comes into close contact with the front end of the needle base, and the needle base stopping portion The movement of the needle base relative to the movable bracket in the forward direction is restricted. 根據請求項2之注射裝置,其特徵在於, 該可動支架具有將該針基保持為圓周面狀的圓周面保持部,該圓周面保持部限制該針基的相對該可動支架的側面方向的位移。The injection device according to claim 2, wherein the movable holder has a circumferential surface holding portion that holds the needle base in a circumferential shape, and the circumferential surface holding portion restricts displacement of the needle base with respect to a side surface direction of the movable holder . 根據請求項2之注射裝置,其特徵在於, 該內容物注入控制機構具有 引導棒,相對該可動支架和該按壓部可移動地進行卡合; 連動棒,緊固在該可動支架上,並相對該按壓部可移動地進行卡合;及 連接棒,延伸為與該連動棒相同的直線狀,後端與該連動棒的前端相對以可進行接觸・分離,該後端位於該可動支架的內部。The injection device according to claim 2, wherein the content injection control mechanism has a guiding rod movably engaged with the movable bracket and the pressing portion; the linkage rod is fastened to the movable bracket and is opposite The pressing portion is movably engaged; and the connecting rod extends in a straight line shape similar to the interlocking rod, and the rear end faces the front end of the linking rod to be contacted and separated, and the rear end is located inside the movable bracket . 根據請求項7之注射裝置,其特徵在於, 該連動棒和該引導棒在可與該按壓部相對的部分的圓周面上具有帶傾斜的卡合齒條, 該按壓部具有與該連動棒和該引導棒的卡合齒條進行嚙合的制動器, 該按壓部構成棘輪機構,該棘輪機構沿接近該可動支架並將該活塞壓入該注射筒內部的方向相對該連動棒和該引導棒可相對移動,該棘輪機構的向離開該可動支架的方向的移動被鎖止。The injection device according to claim 7, wherein the interlocking bar and the guiding bar have a slanted engaging rack on a circumferential surface of a portion opposite to the pressing portion, the pressing portion having the interlocking bar and a latching engagement gear of the guiding rod, the pressing portion forming a ratchet mechanism, the ratchet mechanism being opposite to the linking rod and the guiding rod in a direction approaching the movable bracket and pressing the piston into the inside of the syringe Movement, the movement of the ratchet mechanism in a direction away from the movable bracket is locked. 根據請求項7之注射裝置,其特徵在於, 該可動支架上設置了第1彈性部件, 該可動支架在保持該注射筒的部分的下部具有移動支撐部,該移動支撐部上形成了該引導棒可滑動插入的第1貫穿孔、及前端可滑動插入該連接棒並且位於同一直線上的後端緊固該連動棒的第2貫穿孔, 該可動支架向接近該接觸頭的該前進方向進行移動後,相對該第1彈性部件,從該引導棒和該連接棒向該第1彈性部件施加壓縮力, 藉由該第1彈性部件的回復力,使該可動支架向離開該支撐機構的方向進行移動。The injection device according to claim 7, wherein the movable bracket is provided with a first elastic member having a moving support portion at a lower portion of a portion holding the syringe, the guide rod being formed on the movable support portion a first through hole that is slidably inserted, and a second through hole that is slidably inserted into the connecting rod and that is located on the same straight line and fastens the second through hole of the connecting rod, and the movable bracket moves toward the forward direction of the contact head Thereafter, a compressive force is applied to the first elastic member from the guide rod and the connecting rod with respect to the first elastic member, and the movable bracket is moved away from the support mechanism by the restoring force of the first elastic member. mobile. 根據請求項9之注射裝置,其特徵在於, 在該第1貫穿孔和該第2貫穿孔的內壁上,設置了從該內壁突出的彈簧保持部件, 該引導棒和該連接棒上分別設置了小徑部和大徑部,該小徑部在該引導棒和該連接棒的延長方向上位於該可動支架的中央附近,該大徑部位於該可動支架的前端側, 該第1彈性部件的前端保持在從該引導棒和該連接棒的大徑部向小徑部進行縮徑的側面上,該第1彈性部件的後端保持在該彈簧保持部件上。The injection device according to claim 9, wherein a spring holding member projecting from the inner wall is provided on an inner wall of the first through hole and the second through hole, and the guide bar and the connecting rod are respectively a small diameter portion and a large diameter portion are provided, and the small diameter portion is located near a center of the movable bracket in an extending direction of the guiding rod and the connecting rod, and the large diameter portion is located at a front end side of the movable bracket, the first elastic portion The front end of the member is held on the side surface which is reduced in diameter from the large diameter portion of the guide bar and the connecting rod, and the rear end of the first elastic member is held by the spring holding member. 根據請求項10之注射裝置,其特徵在於, 該支撐機構的後端側的側壁被進行了開口,以供該可動支架的一部分插入,並固定了該引導棒的前端和該連接棒的前端, 在該可動支架向接近該接觸頭的前進方向進行移動時,藉由該支撐機構的側壁與該可動支架的一部分進行接觸,使該可動支架的向該接觸頭的該前進方向的移動停止, 藉由該第1彈性部件的回復力,在該可動支架向從該接觸頭離開的後退方向進行移動時,使該內容物注入被檢體,同時使該針管從預期深度後退至被檢體表面並進行拔針。The injection device according to claim 10, characterized in that the side wall of the rear end side of the support mechanism is opened for a part of the movable holder to be inserted, and the front end of the guide rod and the front end of the connecting rod are fixed. When the movable bracket moves toward the advancing direction of the contact head, the side wall of the supporting mechanism comes into contact with a part of the movable bracket, and the movement of the movable bracket to the forward direction of the contact head is stopped. When the movable holder moves in the backward direction away from the contact head by the restoring force of the first elastic member, the contents are injected into the subject, and the needle is retracted from the intended depth to the surface of the subject. Take the needle. 根據請求項11之注射裝置,其特徵在於, 該支撐機構具有上蓋,該上蓋沿圓周面方向在上方和側方至少覆蓋該注射針和該可動支架的保持該注射針的部分,該可動支架插入該支撐機構的內部。The injection device according to claim 11, wherein the support mechanism has an upper cover that covers at least the injection needle and a portion of the movable holder that holds the injection needle in the circumferential direction and the side, the movable holder is inserted The interior of the support mechanism. 根據請求項2之注射裝置,其特徵在於, 該注射裝置還具有拔針控制機構, 該內容物注入控制機構控制第一階段的針管後退動作,其為一邊使該針管相對被檢體後退至預期位置,一邊使該可動支架接近該按壓部,並將該活塞壓入該注射筒內,以使該內容物注入被檢體, 該拔針控制機構控制第二階段的針管後退動作,其為不使該內容物注入該被檢體,而使該針管從預定位置至少後退至該被檢體的表面並進行拔針。The injection device according to claim 2, characterized in that the injection device further has a needle pulling control mechanism that controls the needle retracting action of the first stage, which is to cause the needle tube to retreat to the object relative to the subject Positioning the movable holder into the pressing portion and pressing the piston into the syringe to inject the contents into the subject, the needle removing control mechanism controlling the second stage of the needle retracting action, which is not The contents are injected into the subject, and the needle tube is at least retracted from the predetermined position to the surface of the subject and the needle is pulled. 根據請求項13之注射裝置,其特徵在於, 該拔針控制機構具有 控制板,具有覆蓋該支撐機構的至少一部分的上表面的上表面板和覆蓋離開了該接觸頭的後端側的側壁的側面板; 2個位置調整銷,具有大徑的頭部,並插入該控制板的該側面板; 第2彈性部件,嵌入該位置調整銷的外側,並被設置為與該控制板的側面板和該支撐機構相接;及 2個彈性銷,設置在該支撐機構的上表面上,一端保持在該可動支架的圓周面保持部的一部分的側面上,並被設置為沿與該注射筒大致垂直的方向延伸, 該支撐機構具有上表面和側面,並形成了用於引導該可動支架的移動的引導路徑, 在該支撐機構的該上表面上,形成了與該彈性銷嵌合的2個溝部, 在該支撐機構的該側面上,形成了供外側嵌入了該第2彈性部件的該位置調整銷插入的作為該引導路徑的入口的插入孔。An injection device according to claim 13, wherein the needle pulling control mechanism has a control board having an upper surface plate covering an upper surface of at least a portion of the support mechanism and a side wall covering a rear end side of the contact head Side panel; 2 position adjustment pins having a large diameter head and inserted into the side panel of the control panel; a second elastic member embedded in the outer side of the position adjustment pin and disposed to be side panel with the control panel And the support mechanism; and two elastic pins disposed on the upper surface of the support mechanism, one end is held on a side of a portion of the circumferential surface holding portion of the movable bracket, and is disposed substantially along the syringe Extending in a vertical direction, the support mechanism has an upper surface and a side surface, and forms a guiding path for guiding the movement of the movable bracket. On the upper surface of the supporting mechanism, two fittings are formed with the elastic pin. In the groove portion, an insertion hole as an inlet of the guide path into which the position adjusting pin of the second elastic member is fitted is formed on the side surface of the support mechanism. 根據請求項14之注射裝置,其特徵在於, 該內容物注入控制機構具有 引導棒,相對該可動支架和該按壓部可移動地進行卡合, 連動棒,緊固在該可動支架上,並相對該按壓部可移動地進行卡合,及 連接棒,延伸為與該連動棒相同的直線狀,後端與該連動棒的前端相對以可進行接觸・分離,該後端位於該可動支架的內部, 該支撐機構的後端側的側壁被進行了開口,以供該可動支架的一部分插入, 該控制板的該側面板被進行了開口,以供該可動支架的一部分插入,並固定了該引導棒的前端和該連接棒的前端, 當該可動支架向接近該接觸頭的前進方向進行移動時,該控制板的該側面板與該可動支架的一部分接觸後,藉由該控制板的該側面板與該支撐機構的該側面接觸,使該可動支架的向該接觸頭的該前進方向的移動停止, 在該第一階段的針管後退動作中,在該控制板的該側面板與該支撐機構的該側面接觸了的狀態下,該可動支架一邊接近該按壓部,該可動支架一邊向後退方向移動, 在該第二階段的針管後退動作中,該控制板的該側面板從該支撐機構的該側面離開,並在該可動支架和該按壓部之間的預定距離被保持的同時,該可動支架向後退方向移動。The injection device according to claim 14, wherein the content injection control mechanism has a guiding rod movably engaged with the movable bracket and the pressing portion, and the linkage rod is fastened to the movable bracket, and is relatively The pressing portion is movably engaged with the connecting rod, and extends in a straight line shape similar to the interlocking rod, and the rear end faces the front end of the interlocking rod so as to be contacted and separated, and the rear end is located inside the movable bracket a side wall of the rear end side of the support mechanism is opened for inserting a part of the movable bracket, the side panel of the control panel is opened for a part of the movable bracket to be inserted, and the guide is fixed a front end of the rod and a front end of the connecting rod, wherein the side panel of the control panel contacts a portion of the movable bracket after the movable bracket is moved toward the forward direction of the contact head, by the side of the control panel The panel is in contact with the side of the support mechanism to stop the movement of the movable bracket in the forward direction of the contact head, and the needle is retracted in the first stage In the state in which the side panel of the control panel is in contact with the side surface of the support mechanism, the movable bracket approaches the pressing portion, and the movable bracket moves in the backward direction, and the needle is retracted in the second stage. In operation, the side panel of the control panel is separated from the side of the support mechanism, and the movable bracket moves in a backward direction while a predetermined distance between the movable bracket and the pressing portion is maintained. 根據請求項15之注射裝置,其特徵在於, 在該拔針控制機構中, 該可動支架上設置了第1彈性部件, 該可動支架向接近該接觸頭的方向移動預定距離後,相對該第1彈性部件,從該引導棒和該連接棒向設置在該可動支架內部的該第1彈性部件施加了壓縮力,之後, 該彈性銷與該可動支架一起向接近該接觸頭的方向進行移動,到達預定位置後,該彈性銷與溝部進行卡合,之後, 在該彈性銷與該支撐機構的該溝部嵌合了的狀態下,該位置調整銷和該控制板向該接觸頭的方向進行移動,並向該第2彈性部件施加壓縮力。The injection device according to claim 15 characterized in that, in the needle pulling control mechanism, the movable bracket is provided with a first elastic member, and the movable bracket is moved by a predetermined distance in a direction approaching the contact head, and is opposite to the first The elastic member applies a compressive force from the guide bar and the connecting rod to the first elastic member provided inside the movable bracket, and then the elastic pin moves together with the movable bracket in a direction approaching the contact head to reach After the predetermined position, the elastic pin engages with the groove portion, and then the position adjusting pin and the control plate move in the direction of the contact head in a state where the elastic pin is fitted to the groove portion of the support mechanism. A compressive force is applied to the second elastic member. 根據請求項16之注射裝置,其特徵在於, 該可動支架接近該接觸頭的方向的力的施加消失後, 作為第一階段,藉由該第1彈性部件的回復力,該位置調整銷和彈性銷的位置不變,藉由該可動支架沿從該支撐機構離開並接近該按壓部的方向進行移動,將該內容物注入該被檢體並使該針管從預期深度後退至預定位置, 作為第二階段,該彈性銷脫離,該位置調整銷和該控制板的位置進行移動,據此藉由該第2彈性部件的回復力,該可動支架和與該引導棒嵌合了的該按壓部進行移動,藉此使該針管從預期深度後退至預定位置。The injection device according to claim 16, characterized in that, after the application of the force of the movable holder in the direction of the contact head disappears, as a first stage, the position adjustment pin and the elasticity are obtained by the restoring force of the first elastic member The position of the pin is unchanged, and the movable bracket moves in a direction away from the support mechanism and close to the pressing portion, and the content is injected into the object and the needle tube is retracted from a predetermined depth to a predetermined position. In the second stage, the elastic pin is disengaged, and the position adjusting pin and the position of the control board are moved, whereby the movable bracket and the pressing portion fitted to the guiding rod are performed by the restoring force of the second elastic member. Move, thereby causing the needle to retreat from a desired depth to a predetermined position. 根據請求項1之注射裝置,其特徵在於, 在該接觸頭的下表面上,該開口部的周邊的表面被構成為相對其他的下表面位於內側,當將該內容物注入該被檢體時,該下表面與該被檢體部分接觸,該開口部的該周邊與該被檢體非接觸。The injection device according to claim 1, characterized in that, on the lower surface of the contact head, the surface of the periphery of the opening portion is configured to be located inside with respect to the other lower surface, when the contents are injected into the object The lower surface is in contact with the subject portion, and the periphery of the opening portion is not in contact with the subject. 根據請求項18之注射裝置,其特徵在於, 在該接觸頭的該下表面的緣部上連續或斷續地形成了沿該下表面的表面方向突出的突起,該突起的上表面以圍繞該開口部的周圍的方式與該被檢體接觸。An injection device according to claim 18, characterized in that a projection projecting in a surface direction of the lower surface is continuously or intermittently formed on an edge portion of the lower surface of the contact head, the upper surface of the projection surrounding the The manner of the periphery of the opening is in contact with the subject. 根據請求項18之注射裝置,其特徵在於, 穿刺動作開始前和拔針動作結束後,該針管的前端位於比該接觸頭的該下表面的與該被檢體接觸的部分還往上的位置。The injection device according to claim 18, wherein the front end of the needle tube is located above the portion of the lower surface of the contact head that is in contact with the object before the start of the puncture operation and after the end of the needle removal operation . 根據請求項1之注射裝置,其特徵在於, 該接觸頭的該開口部相對該接觸頭的下表面沿隨該可動支架的移動該針管穿過的方向和該接觸頭的上下方向的兩叉方向進行了貫穿, 該接觸頭的上表面的該開口部為從與注入點對應的位置開始朝向該支撐機構細長延伸並開口的長孔形狀。The injection device according to claim 1, characterized in that the opening portion of the contact head is opposite to the lower surface of the contact head in a direction in which the needle tube passes with the movement of the movable holder and a bifurcation direction of the up and down direction of the contact head The opening is formed, and the opening portion of the upper surface of the contact head has a long hole shape that extends from the position corresponding to the injection point and that is elongated and opened toward the support mechanism. 根據請求項1之注射裝置,其特徵在於, 在該支撐機構上具有對該可動支架的至少一部分可滑動支撐的圓周面形狀的移動引導軌。The injection device according to claim 1, characterized in that the support mechanism has a circumferential guide rail-shaped moving guide rail slidably supported by at least a portion of the movable bracket. 根據請求項22之注射裝置,其特徵在於, 該支撐機構的該移動引導軌的下部開放,以使該注射器著脫時該針管不進行接觸, 在該接觸頭的下表面上,作為該開口部,在隨該可動支架的移動該針管穿過的方向上,設置了從沿上下方向貫穿的部分開始朝向該支撐機構並到達該接觸頭的該下表面的緣部的切口形狀。An injection device according to claim 22, characterized in that the lower portion of the moving guide rail of the support mechanism is opened so that the needle tube does not make contact when the syringe is disengaged, and the lower portion of the contact head serves as the opening portion In a direction in which the needle tube passes in accordance with the movement of the movable holder, a slit shape is formed from a portion penetrating in the up-and-down direction toward the support mechanism and reaching an edge portion of the lower surface of the contact head.
TW106117879A 2017-05-31 2017-05-31 Injection device TWI731091B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106117879A TWI731091B (en) 2017-05-31 2017-05-31 Injection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106117879A TWI731091B (en) 2017-05-31 2017-05-31 Injection device

Publications (2)

Publication Number Publication Date
TW201902524A true TW201902524A (en) 2019-01-16
TWI731091B TWI731091B (en) 2021-06-21

Family

ID=65803047

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106117879A TWI731091B (en) 2017-05-31 2017-05-31 Injection device

Country Status (1)

Country Link
TW (1) TWI731091B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2047010A (en) * 1935-01-30 1936-07-07 Fairleigh S Dickinson Automatic syringe injector
US2531267A (en) * 1947-10-16 1950-11-21 Harnisch Fritz Hypodermic syringe operating device
KR101203887B1 (en) * 2010-10-28 2012-11-23 (주)디앤케이 Drug injection device for skin resurfacing
DK2623146T3 (en) * 2012-01-31 2017-01-23 Trichoscience Innovations Inc Injection devices
CN202554648U (en) * 2012-04-15 2012-11-28 夏富杰 Medical anesthetic syringe

Also Published As

Publication number Publication date
TWI731091B (en) 2021-06-21

Similar Documents

Publication Publication Date Title
RU2581253C2 (en) Disposable multi-needle head for injections and pre-filled syringe
CN101969898B (en) Ocular implantation device
US7988667B2 (en) Piercing tool
US10426924B2 (en) Placement aid for placing a catheter for diabetics
US20070156096A1 (en) Puncture device
RU2014131467A (en) NON-DAMAGE CANULA
US20140378899A1 (en) Injection devices
JPWO2013141351A1 (en) Automatic injection device
CN111297447B (en) Child lumbar puncture positioning and fixing device and using method thereof
CN109328082B (en) Injection device
JP2018083098A (en) Injection device
KR20210048662A (en) syringe
CN209405474U (en) A kind of novel cavity mirror medicament injection apparatus
US20090030367A1 (en) Soft tissue augmentation by needle-free injection
KR102126008B1 (en) Needle Unit for Drug Delivery System
TW201902524A (en) Injection device capable of preventing the injection needle from falling off from the injection barrel and enabling the syringe to be attached and detached from the injection device
KR101628349B1 (en) Auto-medicator of syringe interchange type
CN209595862U (en) A kind of Pain Management anesthetic care device
CN203029616U (en) Rapid needle insertion acupoint catgut embedding device
US20190184113A1 (en) Assistive Device for Subcutaneous Injections or Implants
CN107495989A (en) Multiple spot puncture needle for testicle
CN116747141B (en) Blunt needle capable of adjusting bending degree of blunt surface and application method thereof
CN219049861U (en) Acupoint injector
CN219846723U (en) Minimally invasive interventional drug delivery device
KR200492506Y1 (en) Drug Delivery Devices